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Galaptin is an S-type S-galactoside binding lectin (subunit M, of 14.5
kDa) found in the lungs and other organs of various vertebrate species. In this
study, galaptin cDNA was inserted in the antisense direction into the pEBVHis
vector and transfected into vascular smooth muscle cell (SMC). Control
cultures were untransfected and vector transfected cells. Then, the effects of
transfection on cell growth, migration, adhesion, morphological changes,
expression of galaptin and mRNA were investigated. Northern blotting
revealed no significant difference in mRNA levels of the recombinant and
control cells. The recombinant cultures that were induced with 0.1 /yM
Dexamethasone (Dex) resulted in a 65% reduction of cell growth, a 50-55%
decrease of expressed galaptin, a 50-60% decrease of cell adherence, a 55-
60% reduction in the total motility and less membrane rufflings when
compared to the control cells. These results demonstrate that galaptin is a
element required for vascular SMC proliferation, adhesion to extracellular
matrix proteins and cell migration.
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The study of Lectins started in March 15,1888 in the assembly hall of
Tartu University (formally Dorpat in Estonia) where Peter Hermann Stillmark
presented his research data (results) for the doctoral degree. His major advisor
was Professor Rudolf Kobert, the director of the college of pharmacology of
the Tartu university. For his dissertation research, Peter H. Stillmark studied
the toxic effects of castor beans proteins {Ricinus communis) on erythrocytes
(red blood cells). He extracted these proteins from pulverized castor beans
with a 10% solution of sodium chloride (NaCI) and precipitated them by
treatment of the extract with magnesium sulfate (MgS04). He called the
isolated proteins ricin. He found that the most interesting property of ricin was
its tendency to precipitate red blood cells. Later, Stillmark and Kobert studied
the effect of ricin on the red blood cell of the goat, rabbit, cow, sheep, dog,
horse, cat and man and found that ricin also agglutinated these red blood cells.
Heinrich Hellin, another graduate student of Kobert discovered that the toxic
extract of the jequirity beans (Abrus precatorius) also caused the red blood
cells to agglutinate. The new agglutinin was called abrin. These early works
on lectin were abandoned when R. Kobert left Tartu University in 1897.
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Between 1906 and 1945, some notable scientists worked on different
aspects of lectins. Among them was Paul Ehrlich of the Royal Institute of
Experimental Therapy, Frankfurt, Germany. Ehrlich studied the inhibitory effect
of the anti-ricin and anti-abrin immune serum on the agglutinating activity of
ricin and abrin. He demonstrated that there was a quantitative relationship
between the amount of antiserum and the amount of antigen it could
neutralize. Using these earlier techniques, he performed the first in vitro
quantitative measurement of antibody. James B. Sumner and Stacey F.
Howell studied the carbohydrate specificity of lectins, and were responsible for
the first isolation of concanavalin A (family of lectin) from extracts of the jack
bean by salt precipitation. In 1936, Sumner and Howell demonstrated that
concanavalin A could also precipitate glycogen from solution.
It was not until 1948 that William Boyd at Boston University and K. 0.
Renkonen at the University of Helsinki independently discovered that certain
crude plant extracts agglutinated red blood cells. In 1954, Boyd called these
blood group-specific plant agglutinins 'Lectins' (from the Latin word legere, to
choose or pick up). In 1960, Peter C. Nowell at the University of
Pennsylvania, Philadelphia, demonstrated that phytohemagglutinin (family of
lectin) of the red kidney bean {Phaseolus vulgaris) is mitogenic, i.e. it has the
ability to stimulate lymphocytes to undergo mitosis. Later, other isolated
lectins like concanavalin A were found to be mitogenic and are inhibited by low
concentrations of monosaccharides like D-mannose. In 1963, Joseph C. Aub
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at the Massachusetts General Hospital in Boston demonstrated that lectins can
preferentially agglutinate malignant cells. He had postulated that the
difference between cancer and normal cells lie in the surface. With the advent
of affinity chromatography in 1965, Irwin J. Goldstein and B. B. L. Agrawal of
the University of Michigan, isolated the first pure concanavalin A (lectins).
They used a column packed with crosslinked sephadex (dextran) which
specifically adsorbed concanavalin A and were able to elute the concanavalin
A from the column with D-glucose. In 1972, the word lectin was generalized
to include all sugar binding and cell agglutinating proteins of non-immune origin
obtained from prokaryotic or eukaryotic organisms.
Studies on lectins and their applications increased in the early 1970s.
During this period, many cellular, biochemical and immunological methods
were employed to study the distributions, properties, biosynthesis and
functions of different lectins in both prokaryotic and eukaryotic organisms. In
1972, following the isolation of pure concanavalin A, it was purified by affinity
chromatography, sequenced and the amino acid composition determined by
Gerald M. Edelman et al of Rockefeller University. Subsequently, the three
dimensional structures of concanavalin A and other lectins were determined at
2 A resolution.
Over the past seven years, our laboratory has focussed on studies
involving the elucidation of the functions of galaptin (a family of lectin) in
different mammalian cell lines that were isolated from primate lung.
4
Mammalian lung is a complex tissue made up of at least 40 different cell
types. Within the alveolus, the following cell types constitute 100% of the
cells found: endothelial cells (43%), interstitial cells (mostly fibroblasts, 32%),
type I (8%) and type II (15%) alveolar epithelial cells and macrophages (3%).
Whitney et al., 1985, measured the ability of several cell types to synthesize
and bind galaptin. Cultured lung fibroblasts and pulmonary arterial endothelial
cells synthesized and bound galaptin; alveolar macrophages bound but did not
synthesize galaptin; type II epithelial cells did not bind or synthesize galaptin.
Other cultured fibroblasts, such as 3T3 fibroblasts, also synthesize galaptin.
We have measured the ability of aortic smooth muscle cells and pulmonary
endothelial cells to synthesize and secrete galaptin (Sanford and Harris-Hooker,
1986). In 1985, Whitney and coworkers suggested that if lung cells
synthesize, secrete and bind galaptin, they could mediate cell-cell or cell-
extracellular matrix interactions that could be an important necessity when
remodeling of the lung is occurring during postnatal development. Galaptin
could also stimulate cell growth, cell motility and alter cellular metabolism of
cells that bind and internalize this lectin. Our laboratory found that lung
galaptin and two plant &-galactoside specific lectins stimulated the DNA
synthesis and proliferation of cultured vascular smooth muscle cells and
pulmonary arterial endothelial cells (Sanford and Harris-Hooker, 1990). These
results indicated that cultures of vascular smooth muscle cells, pulmonary
arterial endothelial cells, and lung fibroblasts would be excellent models to
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study the cellular effects or the regulation of endogenous galaptin expression
but may not be ideal for introducing an inducible galaptin gene. Lung epithelial
cells may be a better model for this purpose; the model could be used to
assess the cellular changes induced by the induction of galaptin expression.
It is interesting that cells that synthesize galaptin also bind exogenous galaptin.
The finding that galaptin stimulates cell proliferation suggests it may function
as an autocrine growth factor. What is not clear is whether inducing the
expression of galaptin by these cells results in a higher proliferation rate or the
mechanism that mediates this effect. However, studies have not been done
to examine whether enhanced-expression or over-expression of galaptin by
cells results in increased proliferation and/or DMA synthesis. A molecular cell
model that would allow for prolonged over expression of galaptin would be
ideal for studies designed to couple proliferation to galaptin expression. This
model would also be extremely useful in investigating the mechanism of action
of galaptin.
Galaptin has been found in many vertebrate tissues, comprising about
0.1 % of the soluble protein. Galaptin is a dimer composed of identical 14 to
15 kDa subunits, easily extracted with lactose, requires a thiol protective
reagent to maintain activity as a lectin and is specifically inhibited by
substances having terminal S-galactosyl residues. The role(s) of this lectin in
development has not been determined and studies addressing its role have not
been done. The lung has two other H-galactoside specific lectins, with
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apparent subunit of about 8 kd and 29 kd, that behave as monomers and
have slightly different specificity of binding to glycoconjugates than the 14 kd
galaptin (Cerra et aL, 1985). Complete amino acid sequences have been
reported for galaptin of rat lung (Clerch et al., 1988), human placenta
(Hirabayashi and Kasai, 1988) and chick skin (Hirabayashi et al., 1887).
Partial sequences have been reported for electric eel (Parautaud et al., 1987)
and bovine (Abbott et al., 1989) galaptin. Galaptins are part of a family of Q>-
galactoside specific lectins which are clearly different from the
asialoglycoprotein receptor family. This family is composed of integral
membrane proteins with large subunit molecular weights and require divalent
cations for activity. Studies of the sequence differences between several
human galaptin cDNA clones suggested that at least three variants of the gene
coding for galaptin are expressed in human tissue (Hirabayashi et al., 1989).
However, more recent hybridization experiments using a cDNA probe for
galaptin from several human cell lines suggest that a single gene codes for
galaptin (Couraud et al., 1989). Partial human and mouse galaptin cDNA and
full length rat and human lung, chick, and human placenta cDNA have been
sequenced and/or cloned (Clerch et al., 1988, Southan et al., 1987, Abbott
and Feizi, 1989, Hirabayashi et al., 1989, Couraud et al., 1989, Wilson et al.,
1989, Yancopoulas and Alt, 1990 and Coen and Scharf, 1990). The galaptin
gene has also been isolated from a chick genomic library and characterized
(Wilson et al 1989 and Botwell et al., 1990). The mRNA for galaptin is
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encoded by four exons separated by three introns and spans the entire 3.1
kilobase gene. In vitro translation studies indicated that galaptin is not
synthesized as a precursor molecule with a signal sequence at the N-terminus
(Yancopoulas and Alt, 1990). A study of free and bound polyribosomes in
several cell lines showed that galaptin is translated on free cytoplasmic
ribosomes (Wilson et al., 1989). These findings raise questions about how
galaptin becomes located in the extracellular matrix.
Several studies have reported on cloning the human galaptin cDNA in E.
coli and the production of recombinant galaptin (Southan et al., 1987,
Yancopoulas and Alt, 1990 and Coen and Scharf, 1990). The protein does
not require post-translational processing, which would indicate the need for a
mammalian system to produce active galaptin. Similar studies have not been
done where the galaptin cDNA or antisense cDNA was inserted into a vector
and transfected into mammalian cells. The studies that have been done leave
several unanswered questions. Since galaptin is apparently made in the
cytosol, how does it become externalized? Does a cell that is induced to
express galaptin have altered cell growth and motility, as suggested by studies
with exogenous galaptin? If so, what are the mechanisms for these effects?
A molecular approach that will result in a model with altered or inducible
galaptin expression is necessary to begin to address these questions. This
model could also address how galaptin affects several aspects of cell growth
and maturation and offer some clues or answers relative to the role of galaptin
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in the developmental process. This approach requires the generation of an
eukaryotic recombinant expression plasmid. The eukaryotic recombinant
plasmid would be generated using a mammalian vector and inserting the
galaptin cDNA in the antisense direction. The recombinant plasmid would be
transfected into cells that normally express galaptin (lung fibroblasts and
vascular smooth muscle cells). These transfected mammalian cells will have
the galaptin antisense cDNA under control of the glucocorticoid promoter. The
cells could be induced by dexamethasone (Dex) to express galaptin antisense
mRNA and used as models to assess the cellular effects of galaptin. In these
studies we constructed a recombinant gene and transfected a mammalian
(vascular smooth muscle) cell line with this construct (expressing antisense
galaptin mRNA). This model was used to characterized cell growth
characteristics, cell motility/migration, and cell morphology. A cell model that
has an inducible galaptin gene would be extremely useful for investigating the
mechanism(s) for the cellular effect(s) of galaptin. The proposed project also
provided support and experience for molecular studies of galaptin. The specific
aims of the research project are to:
1. Generate a recombinant gene containing a pEBVHis vector with
an inducible promoter and galaptin cDNA that is oriented in
antisense direction.
2. Transfect mammalian (vascular smooth muscle) cell lines that
express the galaptin gene with the recombinant vector containing
9
the galaptin antisense cDNA.
3. Assess the transfected cell line for the following:
(a) inducibility of the promoter using dexamethasone,
(b) expression of galaptin antisense mRNA,
(c) alterations in cell growth kinetics, adhesion, migration and
morphology following the induction of galaptin expression.
The long-term objectives of these studies are to use the model
developed to understand the mechanism(s) of galaptin action and further the




Early attempts to purify lectins to homogeneity met with many problems
that are not commonly encountered in the purification of other proteins. These
problems were attributed to the fact that lectins appeared in multiple forms
that possess similar biological activities and that differ only slightly in their
chemical properties. Many lectins are comprised of subunits and undergo
complex association-dissociation reactions, giving rise to multiple forms of the
same lectin that differ only in molecular size. Also, the chromatographic
behavior and the biological activities of lectins may be influenced by the
presence or absence of metals.
Lima bean lectin, isolated by Boyd et al. in 1949, was the first lectin
shown to agglutinate red blood cells. It is specific for type A human
erythrocytes and react strongly with blood group A substance from human
ovarian cyst and hog mucin. In 1953, Walter J. T. Morgan and Winifred M.
Watkins at the Lister Institute, London, first demonstrated that the
agglutination of type A erythrocytes (red blood cells) using the lima bean lectin
can be inhibited by a-linked N-acetyl-D-galactosamine. Also, they
demonstrated that the agglutination of type O blood cells by lotus
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tetragonolobus lectin can be inhibited by a-linked L-fucose. Following the
discovery in 1963 by Aub et al. that wheat germ lipase contains an agglutinin
specific for malignant cells. Burger et al. in 1968 reported the first isolation of
wheat germ agglutinin. The same group was responsible for crystalline
purification of this agglutinin in 1969.
In 1976, Waard et al isolated and characterized B-galactoside binding
lectins of calf heart and lung. These lectins were purified by affinity
chromatography on asialofetuin-sephadex column. The molecular weight of
17 kDa was determined by gel filtration chromatography. The lectin from both
sources bind effectively to and agglutinate trypsin treated rabbit erythrocytes.
In addition, both were inhibited by glucose, immunologically indistinguishable
when tested by the ouchterlony immunodiffusion assay and competitive for
membrane binding sites in a quantitative fashion.
In 1978, Ballard et al studied glucocorticoid binding in various cell
populations isolated from the lung. They used the surfactant producing
alveolar type II cell to determine the presence of glucocorticoid receptors.
They also performed cytosol preparations to determine the specific binding of
both natural and synthetic corticosteroids. They found high binding activities
and equilibrium dissociation activities in freshly isolated populations of rat lung
cells containing mostly alveolar type II cells. These findings indicated that
glucocorticoid receptors are present in both fetal and adult pulmonary type II
cells and in cell lines that originated from these cells. Also the presence of
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specific receptors in the lung appears to be required for the expression of
hormonal responses in glucocorticoid target tissues.
Briles et al (1979) compared the properties of B-galactoside binding
lectins from tissues of calf and chicken. First, they isolated B-galactoside
binding lectins from various calf tissues and chicken hearts by affinity
chromatography on asialofetuin-sepharose. They analyzed the isolated and
purified lectin from various sources by SDS-PAGE, radioiodination of lectins,
radioimmunoassay and immunofluorescence microscopy. They found that
lectins from various tissues of calf exhibit identical migration on SDS-PAGE,
have the same binding specificity, are antigenically cross-reactive and give
lines of identity on both immunodiffusion and radioimmunoassay. These
lectins from various sources also displayed identical isoelectric focusing
patterns and have similar amino acid compositions. Lectins isolated from
chicken hearts exhibit similar general properties, but is clearly different from
the calf lectins. The above findings suggested that the vertebrate lectins are
species specific rather than tissue specific.
In 1980, Powell et al monitored the presence and activities of several
proteins during postnatal rat lung development. These proteins (enzymes)
were angiotensin, elastin and the lectins. They found that the development of
intra-acinar pulmonary arteries and veins approximately parallel the rise in
specific activity of angiotensin converting enzymes. The peak in activity of B-
galactoside binding proteins (lectins) increased to maximum value by day 12
13
and this correlated with formation of cholinergic synapses, alveolarization of
the lung and secondary septal outgrowth between the tip and base. The
concentration of elastin increased 10-12 fold between day 13 to 17 and this
correlated with the thinning of the alveolar septa and the transformation from
a double to single capillary network.
Barondes et al (1981) studied the externalization of an endogenous
chicken muscle lectin during developmental stages using primary muscle
cultures. Using immunohistochemical techniques, they found that lectin which
was diffusely distributed in myoblasts, became localized in myotubes in a
distribution pattern similar to that of the sarcoplasmic reticulum and T tubules.
Lectin was predominantly externalized later in development. These findings
suggested that externalization may have occurred by migration in the T tubules
which are continuous with the extracellular space.
In 1982, Sanford et al used immunological procedures to localized S-
galactoside binding protein in a plasma membrane fraction isolated from
immature and adult rat lung. Lectin associated with rat lung subcellular
fraction was detected by measuring the specific binding of [^H]-anti-lectin IgG.
All the subcellular fractions from immature rat lung showed some specific
binding of pH]-anti-lectin IgG. The plasma membranes, mitochondrial and
microsomal fractions showed a similar binding to [^H]-anti-lectin IgG but
binding was greater in mitochondria than microsomes and plasma membranes.
In the adult rat lung, the binding of anti-lectin IgG to membranes was similar
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to that observed in the immature rat lung. Immunofluorescence staining of
cultured chick embryo fibroblasts and chick myoblasts suggested that S-
galactoside lectins associated with these cells are predominantly intracellular.
In 1983, Roff et al isolated and characterized carbohydrate binding
proteins from 3T3 fibroblasts. The 3T3 fibroblasts were homogenized,
solubilized with Triton X-100 and fractionated on sepharose columns
covalently derivatized with asialofetuin. Three distinct carbohydrate binding
proteins (CBP's) eluted from the affinity column with molecular weights of
13.5 kDa, 16 kDa and 35 kDa, respectively. These CBP's showed similar
properties by agglutinating rabbit erythrocytes (red blood cells), specifically
recognizing galactose containing glycoconjugates, requiring B-mercaptoethanol
for activity and lack of interaction with one another. To them, it appeared that
CBP-35 was a new protein that could bind to galactose containing
carbohydrates.
Powell et al (1984) studied the properties of B-galactoside-binding
protein (galaptin) isolated by affinity chromatography on
carboxyamidomethylated galaptin sepharose. The homogenates prepared from
fresh 13 day old rat lung were repeatedly centrifuged with appropriate buffers
and subjected to chromatography on CAM-galaptin-sepharose column.
Analysis of the galaptin purified on SDS-polyacrylamide gel electrophoresis
showed molecular weights of 20 kDa, 16 kDa and 7.5 kDa. They were able
to inhibit binding of galaptin to asialo-orosomucoid. They also observed that
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these galaptin's required high concentrations of exogenous thiol reagents such
as dithiothreitol or S-mercaptoethanol to maintain their activity.
Cerra et al in 1985, characterized both immature and adult rat lungs that
contain three soluble l^-galactoside binding proteins. The molecular weights
(14.5 kDa, 18 kDa and 29 kDa) were determined by 12.5% SDS-
polyacrylamide gel electrophoresis and gel filtration chromatography. All of
these lectins agglutinated erythrocytes and required thiol protective groups for
activity. The amino acid compositions of these proteins are, however,
strikingly different. Also, the 14.5 kDa and 18 kDa lectins were not
proteolytic products of the 29 kDa lectins since antibodies raised against each
showed considerable specificity when reacted with all three in either native or
denatured form.
In 1985, Whitney et al studied the synthesis and binding of lactose-
specific lectin in isolated lung cells. Using binding and releasing assays, they
found that: cultured lung fibroblasts and pulmonary artery endothelial cells
synthesized and bound lectin; alveolar macrophages bound but did not
synthesized lectin; and alveolar epithelial type II cells neither bound nor
synthesized lectin. So, lectin binding to isolated cells suggested a function in
promoting cell-cell and/or cell-extracellular interactions.
The second half of the 1980s saw a shift in the direction of the study
and applications of lectins. With the technical advances in molecular biology,
many investigators started to study the gene(s) that express lectins in different
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tissues. A common property of l^-galactoside binding lectins is that they
undergo marked tissue specific changes in expression during development. A
good example can be seen in chicken muscle lectin which is abundant in
embryonic development but becomes scarce in adult life. So, in order to study
the regulation of expression and biological functions in both prokaryotic and
eukaryotic lectins, many investigators began isolating the gene(s) that encode
them. Between 1986 and 1994, many partial and complete nucleotides and
amino acid sequences were reported for families of lectin from different
sources, for example: chick skin; rat lung; human placenta; liver; spleen; and
electric eel.
In 1986, Gitt and Barondes constructed recombinants containing human
hepatoma cDNA and expression vector, gt^ 1. They isolated two human
hepatoma cDNA clones that partially encode the primary structures of proteins
that are variants of 8-galactoside binding lectins. Sequencing of the two
inserts showed that at least three human genes encode protein related to
human lectin. The nucleotide sequences of both clones showed some
homologous regions. The proteins encoded by clones 1 and 2 were
immunologically related to rat lung 14.5 kDa lectin but they showed no cross¬
reaction with antiserum raised against the rat lung 29 kDa lectin.
Kajikawa et al (1986) examined the ability of the human placenta lectin
to induce release of a cytotoxic factor from macrophages. They incubated J-
774.1 cells or human peritoneal monocytes with 10% heat-inactivated FCS
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and human placental lectin for 18 hr at 37°C in 5% COj. The cytotoxic
activity of the culture supernatants was determined by measuring their ability
to kill L929 cells. They found that human placenta lectin induced release of
cytotoxin from both murine macrophage cells and human peritoneal
monocytes. The induction of cytotoxin release may be one function of internal
lectins.
Ohyama et al (1986) sequenced cDNA for chick 14 kDa B-galactoside
binding lectin that was cloned into pBR322. To their surprise, the translated
protein did not include any cleavable signal sequence which would allow it to
exit the cell and become localized in the extracellular matrix. The nucleotide
sequences showed some regions homologous to those in discoidin I, an
extracellular matrix lectin that lack signal peptide. These findings showed
some relationship between the two lectins irrespective of their phylogenetic
origins.
Southan et al in 1987 determined the amino acid sequence of B-
galactoside binding bovine heart lectin. The bovine lectin nucleotide sequence
showed 70%, 40% and 85% homology to the three published sequences of
two cDNA clones from a human hepatoma library and partial sequences of
human lung lectin. So, the immunological cross reactivity within this group of
proteins might be related to their amino acid sequence homology.
In 1987, Clerch et al used biochemical and molecular biology techniques
to study the developmental regulation of rat lung lectin gene expression.
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Northern blotting showed that the mRNA level increased at six days of age and
treatment with dexamethasone inhibited this increase. Southern blotting
revealed the presence of one lectin gene. These results indicated that the
postnatal increase in lectin synthesis is regulated pretranslationally and by an
increased efficiency of translation.
In 1988, Jia et al determined the complete nucleotide sequence of a
cDNA clone expressing carbohydrate protein 35 (CP35) that is found in the
nucleus of mouse 3T3 fibroblasts. The amino acid sequence revealed two
domains of homology. The amino terminal region that is homologous to
certain regions of heterogeneous nuclear ribonucleoprotein (hnrp) complex and
the carboxyl terminal region which is homologous to 6-D-galactoside specific
lectins.
Clerch et al (1988) sequenced a full length cDNA for rat lung B-
galactoside binding protein. The deduced amino acid sequence showed that
the amino terminal alanine is blocked with an acetyl group. It also revealed a
high degree of homology only with other vertebrate lectin sequences. The
biochemical analyses indicated that the 14 kDa lectin exist predominantly as
a single protein. They used circular dichroism, analytical ultracentrifugation
and computer analysis of primary structure to deduce the biochemical
compositions. It was found that the 14 kDa protein is primarily hydrophilic
with an asymmetric, elongated structure consisting of approximately equal
amounts of a helix, B sheet, B turn and random coil.
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In 1988, Ohyama et ai isolated and characterized a cloned segment for
chick 14 kDa (l-galactoside binding lectin from a genomic DNA library.
Southern blotting revealed that the mRNA for this lectin is encoded by a 3.1
kilobase gene consisting of four exons separated by three introns. The first
exon encodes only two amino acid residues of the N-terminus of the mature
protein and the other three exons encode one of the three repeating sequences
found in this lectin. The translation initiator - ATG is located just before the
codon for the N-terminal amino acid of the mature protein. These findings
suggested that this lectin is synthesized without an N-terminal cleavable signal
sequence.
In 1989, Ideon et al isolated and cloned cDNA for 14 kDa l^-galactoside
binding lectin from HL-60 cells and human placenta. Synthetic oligonucleotide
probes were used to screen a lambda gtIO HL-60 cDNA library. Biochemical
analysis showed that this protein was not glycosylated. Northern and
Southern blottings demonstrated that the 14 kDa lectin is encoded by a gene
consisting of four exons.
Abbott et al (1989) determined the full length cDNA for the 14 kDa
soluble B-galactoside binding lectin from a bovine fibroblast cDNA library.
When compared to the previously derived amino acid sequence of bovine heart
lectin, eight differences were observed in the amino acid sequence
compositions. This sequence showed some regions homologous to that of IgE
binding protein. In both 14 kDa lectin and IgE binding protein, the epitopes
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were identified as tetrapeptide sequence W-G-A/S-E/D by two monoclonal anti-
bovine lectin antibodies. The tetrapeptide sequence may be responsible for the
induction (in rabbit and Lewis rat) of experimental allergic encephalomyelitis by
myelin basic protein.
Hirabayashi et al (1989) inserted cDNA for a 14 kDa human S-
galactoside binding lectin into expression plasmid pH4GAL and the lectin
protein was expressed in competent E. coli cells. The recombinant lectin was
purified by affinity chromatography on an asialofetuin sephadex column.
Western blotting demonstrated the presence of 14 kDa in cells that were
transfected with the recombinant. Also, the nucleotide sequence of the
recombinant lectin was indistinguishable from the human placenta derived
lectin except that the N-terminal amino acid was not acetylated.
In 1990, Lee et al studied the binding characteristics of galactoside
binding lectin (galaptin) from human spleen using galactosides, galactose-
terminated disaccharides and different glycopeptides as inhibitors in the
binding assay. Aminohexyl lactoside was attached to divinyl sulfone-activated
sepharose, followed by binding to [’^®l]-galaptin. They found that all a-D-
galactopyranosides with non-sugar aglycon were better inhibitors than the
corresponding IS-D-galactopyranosides. Also, s-galactosides were better
inhibitors than the corresponding o-galactosides. The binding of galactose to
this lectin is not cooperative, i.e. the binding at one site does not facilitate the
binding at another site.
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In 1990, Allen et al studied the roles of galaptin in ovarian carcinoma
cell adhesion to extracellular matrix in vitro. Using enzyme-linked
immunoadsorbent assay (ELISA) and immunoprecipitation, galaptin was found
to be a major protein of the A121 ovarian carcinoma cells. This is because
surface receptors for galaptin have been identified in ovarian carcinoma and
mesothelial cells isolated from patient effusions. When extracellular matrix
(ECM) was treated with lactose, galaptin receptor density:binding sites
increased. Pretreatment of A121 cells with galaptin, however, inhibited
adhesion to ECM. These results suggested that early adhesion events may
require ECM bound galaptin and cell surface galaptin receptors.
Ahmed et al (1990) purified galaptin by affinity chromatography on an
asialofetuin sepharose column. The carbohydrate binding specificity of
galaptin was measured by the change in binding efficiency of galaptin to
asialofetuin in the presence and/or absence of inhibitors. Here, polyclonal
rabbit anti-galaptin serum and anti-rabbit IgG peroxidase conjugate were used
to measure the concentration of galaptin that bind to asialofetuin. Galaptin
was found to have a site as large as the disaccharide. The disaccharides
having non-reducing-terminal&-galactosyl residues linked (1,3), (1,4) and (1,6)
to glucose or N-acetylglucosamine (GalNAc) were better inhibitors than free
galactose. They also determined that free or glucosidically linked GalNAc did
not bind to lectin. These results showed that hydroxyl (OH) groups at carbons
4 and 6 of galactose and the hydroxyl group at Carbon 3 of GIcNAc in
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GalS(1,4)GlcNAc are required for lectin-sugar interactions.
In 1990, Sanford et al studied the effects of various B-galactoside
specific lectins on the growth of vascular cells in vitro. Various concentrations
(2.0, 3.5 and 7.0 //g/ml) of plant lectins and rat lung lectin were added to
confluent and subconfluent cultures of smooth muscle cells (SMC), pulmonary
arterial endothelial cells (PAEC), and bovine aortic endothelial cells (BAEC).
Peanut lectin stimulated SMC and PEC to proliferate but did not stimulate
BAEC to proliferate. The observed increase in proliferation was dose
dependent and could be inhibited by 50 mM lactose. The peanut lectin and rat
lung galaptin increased the incorporation of [^H]-thymidine into DNA in PEC by
30% and 150% using 10% fetal bovine serum (FBS). However, under low
FBS condition, both lectins showed about the same incorporation of [^H]-
thymidine into DNA. Also, both lectins produced a 30% increase in DNA
synthesis by using 10% FBS and a 200% increase by using low FBS. These
findings indicate that B-galactoside specific lectins may have mitogenic activity
toward vascular cells.
Offner et al (1990) used recombinant human B-galactoside binding lectin
to suppress the clinical and histological symptoms in Lewis rats with
autoimmune encephalomyelitis. First, cDNA from human placenta was cloned
and expressed in E. coli. Injection of this recombinant immunomodulatory
lectin (rlML-1) into Lewis rats inhibited the manisfection of both clinical and
histological symptoms. It appeared that rlML-1 blocked sensitization of
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encephalitogenic BP-specific T cells and induced BP-dependent suppressor
cells. These results demonstrated that rlML-1 may be used as an agent for
treatment of autoimmune diseases and transplantation.
In 1990, Sharma et al studied the correlation between the human
splenic galaptin to other B-galactoside-binding lectins found in vertebrate
tissues. Here, SDS-Polyacrylamide gel electrophoresis, isoelectric focusing,
circular dichroic method, reversed HPLC and Western blotting were used in
these analyses. Similar to other tissues, galaptin isolated from human spleen
showed subunits of 14.5 kDa by SDS polyacrylamide gel electrophoresis and
Western blotting. Circular dichroic analysis revealed the presence of 40% beta
structure, many random coils and 10% or-helix structure. Galaptin isolated
from human spleen revealed a high degree of amino acid homologous to that
of human placenta. This study demonstrated that all B-galactoside binding
lectins regardless of source, have conserved amino acid sequences and
probably originated from a common ancestor.
Oda et al (1991) cloned and sequenced cDNA encoding the human
galactoside binding lectin from breast carcinoma. This gene encodes a protein
of 250 amino acids that is over 80% homologous to a similar protein found in
mice and rats. The deduced amino acid sequence has an N-terminal region
(consisting of two domains) and a C-terminal region.
In 1991, Holthoefer et al used immunocytochemical methods to study
the effects of different cell-type specific monoclonal and polyclonal antibodies
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and lectins on the early morphological epithelial outgrowth of rat renal
glomerular cells in culture. They found that early glomerular cultures consist
of mesangial, endothelial and presumably parietal epithelial cells. However,
podocytes couldn't be visualized under the various growth conditions tested.
These results demonstrated that glomerular podocytes were arrested during
early epithelial growth.
Allen et al (1991) isolated and characterized l^-galactoside binding lectin
from human buffy coat cells (peripheral leukocytes) and spleen by affinity
chromatography. Lectin from both cells showed similar molecular weights of
32 kDa and an isoelectric point range of 4.6-4.85. They synthesized cDNA
using mRNAs isolated from both cell lines. The cDNA's were amplified by PCR
and partially sequenced. The derived amino acid sequences were identical in
residues 6-65, 84-114 and 118-126. Immunohistochemical assays revealed
that galaptin was distributed throughout the cytoplasm of B lymphoblastoid
cells rather than being localized on the cell surface.
In 1991, Ozeki et al isolated and sequenced an 11.5 kDa subunit of D-
galactoside binding lectin from sea urchin eggs. The 105 amino acid
containing lectin was sequenced using the intact S-carbamoylmethylated
protein and peptides generated by digestion with Achromobacter protease I.
Surprisingly, this subunit has no regional similarity to any sequence in the data
bank, suggesting that this may be a new galactoside binding lectin.
In 1992, Akimoto et al used immunohistochemical methods to study the
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changes in the expression pattern of the 14 kDa lectin gene during epidermal
differentiation in vivo and in vitro. The 14 kDa lectin was detected mainly in
the intermediate layer of the epidermis inside the cells by HRP staining
followed by in situ hybridization using cDNA as a probe. More lectin was
detected in 17 day old embryo than in 13 day old embryo. Vitamin A
suppressed the expression of the gene in the skin explants. The same staining
pattern was observed in differentiating epidermis in vitro.
Sheldon et al (1992) presented the first evidence that N-glycans and N-
glycanases function in the regulation of lectin synthesis from the precursor
glycoprotein, concanavalin A. They isolated and purified the glycoprotein
precursor by affinity chromatography from microsomal membranes. They
demonstrated that mature active lectin from microsomal membranes were
processed through six intermediate precursors. This study showed that in vitro
deglycosylation alone was sufficient to convert the precursor to an active
carbohydrate binding lectin.
In 1992, Mann et al used 14 different lectins to investigate the
expression of saccharides by cerebral microvessels (MBV) in aging patients and
in patients with Alzheimer's disease (AD) and Down's syndrome (DS). It is
common in aged persons (over 50 years) to have increased binding, amount
of and diversity of glycoproteins due to thickening of the basement membrane
(BM) of cerebral microvasculature. The binding of e-PHA, 1-PHA and PAA
increased in AD patients and in persons over 50 years with DS. These specific
26
increases in AD and DS patients may reflect selective disease-related changes
in basement membrane. These findings suggested an impaired blood-brain
barrier function.
Kvanta et al (1992) studied the effect of mitogenic lectins on c-Fos and
c-Jun protein levels as well as on activator protein-1 (AP-1) binding and
enhancer activity in JurkatT-cells. Stimulating the cells with Con A and PHA
increased protein levels of both c-Fos and c-Jun. There was little effect of the
lectins on the elevation of either intracellular Ca super(2 4-) or cAMP levels.
The mitogen-induced increase of c-Fos and c-Jun immunoreactivity was
inhibited by H-7 and H-8 (kinase inhibitors) with high specificity for protein
kinase C.
In 1992, Menghi et al used immunohistochemical analyses to study the
functions of lectin in the mouse submandibular salivary gland. In the anti-WGA
staining method, the male submandibular gland appeared more reactive than
that from female mice. The reaction was localized within the acini of female
and convoluted granular tubules of males; while the anti-PNA staining method
showed more positive reaction in females (within the acini) than male mice.
These results demonstrated that this lectin could function in packaging,
immobilization and transport of glucidic (glycocidic) material.
Gitt et al (1992) isolated and sequenced a full-length cDNA that
encoded a homodimer protein with two identical subunits with a molecular
weight of 14.65 kDa. This protein (L-14-1) was eluted from an affinity column
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with lactose, and was found to have 43% amino acid sequence region
homologous to its relative L-14-II. However, although like, L-14-II, L-14-1 is
encoded by a gene consisting of four exons. The genomic upstream region
differs significantly from L-14-II.
In 1992, Sharma et al used Western blotting and immunoprecipitation
fluorographic analysis to show that a previously identified 15 kDa R-
galactoside binding protein, synthesized in vitro by human peripheral
leukocytes, is comprised of three different polypeptides. Biochemical analyses
showed that one of these polypeptides is related to the 15 kDa lectin isolated
from human spleen. Fragmentation of this 15 kDa lectin with cyanogen
bromide (CNBr) yielded 6.2 kDa and 8.6 kDa fragments. The 15 kDa lectin
gene was partially sequenced and the amino acid compositions did not
revealed a relationship to any known lectin.
Sanford et al (1993) studied the regulation of activity and synthesis of
lung B-galactoside specific lectin (galaptin) by dexamethasone (Dex) in 1 to 15
day old rats. Administration of Dex for 2 to 5 days showed little effect on
galaptin activity and synthesis. But, administration of Dex for 10 to 11 days
increased galaptin activity and synthesis. Data from this study also suggested
that soluble and membrane bound or particulate bound galaptin might be
synthesized and activated by a similar mechanism. These studies also
suggested that the duration of exposure to Dex is important to its effect on
galaptin synthesis and activity.
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In 1993, Timoshenko et al studied the induction of superoxide release
from human neutrophils by the galactoside specific lectin from mistletoe
(Viscum album). Of the twelve different lectins tested, Viscum album (VAA)
lectin exhibited the highest activity and this activity was completely inhibited
by lactose. The release of superoxide increased with the addition of agents
like phorbol 12-myristate 13-acetate (PMA), digitonin and N-formylmethionyl-
phenylalanine (FMLP). These compounds have remarkable roles in host
defense against infection and tumors. But the addition of modulators like
amiloride, trifluoperazine and N-ethylmaleimide did not induce superoxide
release. The tetrameric mannose-specific Con A induces oxygen release from
human neutrophils similar to the effect of VAA. Presently, the mechanism of
VAA induction is unknown. These findings suggested that superoxide release
by Viscum album lectins can be enhanced by other classes of inductors.
Poirier and Robertson in 1993 monitored the expression of LI 4 S-type
lectin during development in mice. They approached this by introduction of a
null mutation in the Z.ecf14 gene using homologous recombination in
embryonic stem cells. This resulted in mice in which both alleles of the Lect^ 4
gene were disrupted. Surprisingly, they found that mice lacking the Lect14
gene appeared to develop as normally as the wild type mice. The mutants
exhibited normal viability and fertility. But, more studies are needed in the
analyses of the animals in order to determine if Lect14 expressed protein is not
needed during embryogenesis and in the adult tissues or if the function(s) of
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Lect14 is/ are largely compensated for in vivo.
In 1993, Huflejt et al studied the phosphorylation of serine 6 and serine
12 residues of L-29 soluble lactose-binding lectin by casein kinase I in
confluent 3T3 fibroblasts. If L-29 lectin is phosphorylated in cultured cells,
one may then attempt to determine if covalent modification of the L-29 lectin
modulate intracellular function(s) during the cell cycle in polarized epithelial
cells. They used phosphoamino acid analysis with casein kinase I,
chymotryptic and endoproteinase digested the Asp-N and NHj-terminal
fragments which were generated by Edman degradation, to show that
phosphates were incorporated 90% on serine 6 and 10% on serine 12,
respectively. They did not, however, identify the intracellular ligand for the L-
29 lectin. As a result, the ligand(s) for L-29 lectin need to be identified in
order to specifically determine the significance of its phosphorylation.
Ochieng et al in 1993 studied the membrane expression, activities and
disposition of the 30-kDa galactoside binding lectins (collectively referred to
f
as GBL-30), and the recombinant homologue lectin (rhL-31). They also studied
the structure-function relationship of a recombinant GBL-30. After purification,
they were able to identify the lectin as rhl-31. The techniques used included:
one step affinity chromatography on immobilized asialofetuin followed by
elution with lactose, cell surface labeling, immunohistochemical staining and
ligand binding. The protein rhl-31 was previously identified by Drickamer et al
(1988) and Foddy et al (1990) as a cell surface component of tumor cells.
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However, as such, it lacks both leader and transmembrane domain sequences.
This leaves unanswered the question as to the transport to and deposition on
the cell surface. While GBL-30 lacks leader and transmembrane domains, it
has been shown to contain collagen-like sequences which are absent in other
S-lectin families. It has been shown that GBL-30 functions as a dimeric
molecule (the stability of which might come from disulfide bonds) but may also
exist as larger aggregates. These researchers postulated that the collagen-like
sequences could serve to stabilize the dimer either as soluble or insoluble
forms or can act as a "spacer" separating the functional, globular domain of
GBL-30 from the cell surface similar to its proposed role in pullulanse (Tong et
al., 1988).
Skrincosky et al in 1993 investigated the presence of galaptin in the
extracellular matrix (ECM) and its role(s) in the adhesion of A121 human
ovarian carcinoma cells to ECM via specific cell surface carbohydrate
receptors. Treatment of cells with lactose and S-galactosidase decreased
adhesion of A121 cells to the ECM by 65% while neuraminidase treatment
increased adhesion by 30%. They isolated, purified and characterized these
receptors {lamp-1 and lamp-2) that mediate this interaction. Western blotting
and metabolic labeling of A121 cells revealed a unique cellular protein of
molecular weight 110 kDa. Also, indirect immunofluorescence using specific
antibodies facilitated detection of cell surface antigenicity of lamps. This
implicated lamp-1 and lamp-2 as the cell surface receptors involved in the
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galaptin mediated adhesion of ovarian carcinoma cells to ECM.
Post et al (1994) examined the effects of platelet-derived growth factor
(PDGF) or PDGF-like molecules on the fetal lung morphogenesis. They used
PDGF-15 chain specific antisense oligodeoxynucleotides to inhibit PDGF-S
translation in the embryonic rat lung explant. Using immunoblot analysis, they
reported an inhibition of DNA synthesis and about 50% inhibition in the
expression of PDGF-S mRNA, but not PDGF-a mRNA, in the lung explant.
Although morphogenic analyses of antisense treated cultures revealed a
significant reduction in the lung size when compared to the control cultures,
the number of terminal buds of the explants was not significantly affected by
antisense PDGF-S treatment. Their studies suggested that PDGF-S may be
involved in the regulation of growth but not the degree of branching of
embryonic rat lung.
In 1994, Crouch et al used ultrastructural and biochemical techniques
to examine the quaternary structure and properties of native rat pulmonary
surfactant protein D (SP-D). Electron microscopy of freeze-dried preparations
revealed that SP-D is a homogenous population of molecules with four rod-like
arms. Each of these arms is 46 nm in length and 8-9 nm in diameter. This
structure is consistent with hydrodynamic studies that predicted a highly
asymmetric and extended molecule. SP-D migrated at 43-kDa on SDS-
polyacrylamide gel electrophoresis. Upon digestion with bacterial collagenase,
SP-D generated a COOH-terminal carbohydrate binding fragment and a smaller
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peptide that contained interchain disulfide bonds. Their studies established
that rat SP-D is assembled as a homopolymer of four identical trimeric subunits
that are associated within their amino-terminal domains by interactions
stabilized by interchain disulfide bonds.
Chiariotti et al in 1994 investigated the expression of soluble lectin L-14
gene induced by thyrotropin (TSH) stimulation in FRTL-5 (normal rat thyroid),
FRTL-5 KiMSVts (kirsten murine sarcoma virus) and CEINGE CL3 (encephalon
derived) cells. The L-14 lectin was suppressed by retinoic acid (RA) in
transformed neural cells. Northern blot analysis showed a significant increase
of L-14 mRNA following TSH stimulation but the L-14 mRNA was greatly
inhibited in cells treated with retinoic acids. Cell growth was assessed by
seeding sparsely in 24 well plates. They observed a decrease in L-14
expression which was equated with loss of all specific differentiated functions
and with acquisition of a high tumorigenic phenotype. A reversion of the
transformed phenotype and growth inhibition caused a decrease of L-14
expression only when the differentiated phenotype was also restored as in the
oligodendrocytes. But L-14 remains elevated in the reversed transformed
phenotype and growth inhibited cells without reactivation of the differentiated
functions as in the case of thyroid cells that were transformed with the
KiMSVts mutant. They also demonstrated that removal of retinoic acid
restored both the transformed undifferentiated phenotype and high L-14
expression. These results show that L-14 may play some roles in cell cycle
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progression, thereby implicating L-14 in specific differentiation function{s) of
different cell lines.
Wang et al (1994) examined the expression of surfactant proteins A, B
and C (SP-A, SP-B, and SP-C) in 12 to 15 day embryonic rat lung. The
surfactant proteins are believed to be putative markers for alveolar epithelial
type II cells. Reverse transcriptase polymerase chain reaction (RT-PCR) and
Northern blot analysis revealed that at 12 days gestation, the embryonic rat
lung lacked detectable mRNAs for any of the three surfactant proteins. These
three proteins, however, were present in embryonic rat lung at 13 to 15 days
gestation. The detection of SP mRNAs was limited to the epithelial cells and
not in cells destined to become type II cells. This is because epithelial cells
form parts of the trachea, bronchial ducts and prealveolar region of distal lung.
Of the three SPs, only SP-C was detected in the brain and kidney. These
results suggest that none of the three surfactant proteins are specific for cells
destined to become pneumocytes.
In 1994, Sato and Hughes studied the regulation of secretion of the
galactoside binding protein, Mac-2, in murine peritoneal macrophages, and
evaluated if surface expression of this protein was correlated with the fine
regulation of oligosaccharide structures, since such regulation is known to
accompany membrane remodeling in macrophage recruitment and maturation.
They found that with the elicitation or activation of macrophages, about 30%
of Mac-2 was constitutively secreted and that secretion was markedly
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stimulated by calcium ionophore (A23187). However, only thioglycollate-
elicited macrophages expressed cell surface l\/lac-2 and binding with cell
surface carbohydrate structures was about 80%. In this study, Sato and
Hughes also determined that the major determinants responsible for Mac-2
surface expression were polylactosamine on all macrophages and a-galactosyl
residues on thioglycollate-elicited macrophages. These results suggested that
the surface expression of Mac-2 is developmentally regulated and correlated
with the appearance of a-galactosyl residues on the cell surface glycoproteins.
Jordan and Goldstein (1994) constructed a recombinant lima bean lectin
gene using gt^ 1. This recombinant was ligated into an expression vector
pET3d and expressed in Escherichia coii using T7 RNA polymerase. SDS-
polyacrylamide gel electrophoresis and western blot analysis showed that the
cloned portion of the gene encodes the a subunit of the lima bean lectin and
recognizes terminal a-D-GalNAc groups and agglutinates human type A
erythrocytes. The determined isoelectric point of 5.86, amino acid and
nucleotide sequences have significant overall homology to other leguminous
plant lectins. However, this isolated recombinant lima bean lectin (rLBL)
showed several significant differences in mobility on gel filtration, aggregation
in solution and CD spectrum when compared to the native lima bean lectin.
These differences might be quantitative differences in the carbohydrate
moieties of these proteins.
It is interesting in finding out that many studies have done in different
35
aspects of galaptin and other families of lectin as presented above. Some of
these studies left several unanswered questions. This study was intended to
answer some of these questions which include proliferation, adhesion and
migration of cells during postnatal lung development in vertebrates. As stated
earlier, the function(s) of galaptin in lung development has not been determined
and few studies have addressed these issues. Galaptin is synthesized in the
cytoplasm without a signal peptide(s). If cells are induced to express galaptin,
do these cells have altered cell growth, adhesion, and migration? To attempt
to address these questions, a molecular approach of recombinant cell model
with altered or inducible galaptin expression was constructed. This model
addressed how galaptin affects many aspects of cell growth, adhesion,





The Vascular Smooth Muscle cells from subhuman primate were
obtained from the laboratory of Dr. Sandra Harris-Hooker (Department of
Pathology and Medicine) at Morehouse School of Medicine, Atlanta, GA.
These cells were subcultured into 150 cm^ culture flasks and incubated at
37°C in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal
bovine serum (FBS) and 1 x streptomycin/penicillin antibiotics. The cell culture
media, antibiotics, fetal bovine serum and glutamate were purchased from
GIBCO-BRL Company, Gaithersburg, MD and Atlanta Biological Company,
Atlanta, GA. The selective serum free media used in the screening of the
recombinants and in the metabolic [^®S]-methionine labeling of galaptin were
bought from ICN Radiochemicals company, Irvine, CA. All other sterilized cell
culture supplies like flasks, pipets, six, eight and twelve well plates were
purchased from Fisher Scientific Company, Pittsburgh, PA and Corning Glass
Company, New York, NY. Dexamethasone (Dex) and cell adhesion products
such as laminin, ECL-matrix and collagen were purchased from Sigma Chemical
Company, St Louis, MO.
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The SDS-polyacrylamide gel electrophoresis chemicals used in this study
were purchased from Sigma Chemical Company, St. Louis, MO and SE 400
vertical gel units were purchased from Hoeffer Scientific Company, San
Francisco, CA. The silver staining plus chemicals and protein low molecular
weight standards were purchased from BioRad Scientific Company, Hercules,
CA. The ECL western and/or immunoblotting kits were bought from
Amersham Life Science, Arlington Heights, IL. All other protein gel
electrophoretic supplies were purchased from Fisher Scientific Company,
Pittsburgh, PA. Chemicals for nucleic acids (RNA and DMA) gel electrophoresis
were purchased from GIBCO-BRL life technologies, Bethesda, MD and Sigma
Chemical Companies. The horizontal agarose gel units were bought from
Jordan Scientific Company, Bloomington, IN.
RNA isolation kits, cDNA synthesis kits and pEBVHis vector used in this
study were purchased from Invitrogen Company, San Diego, CA. The
polymerase chain reaction kits were bought from Perkin Elmer and Promega
Company, Bloomington, IN. DNA restriction endonucleases such as Hind III,
EcoR I, Sa! I and Sma I were purchased from Invitrogen Company. Molecular
weight standards: PhiX174 RF DNA Hae III digest were bought from New
England Biolabs in Beverly, MA, 0.16-1.77 kb RNA ladder and 1 kb DNA ladder
were purchased from GIBCO-BRL life technologies. Nucleotide sequencing kits
were purchased from USB, Cleveland, OH. Mini-plasmid isolation kits were
purchased from Invitogen Company and/or RPM Company, La Jolla, California
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and DNA isolation kits were bought from Puregene, Minneapolis, MN. All
other supplies for molecular biological analyses were purchased from Sigma
Chemical Company and GIBCO-BRL Company. All glassware and solutions
were treated with diethyl pyrocarbonate (for RNA analyses) and autoclaved to
render them nuclease (RNase and DNase) free.
The bacterial strain Top-10 E. co//used in transformation was bought
from Invitrogen Company. The components for the preparation of bacterial
culture media including tryptone, glucose, sodium chloride and other materials
for culturing bacteria were purchased from Sigma Chemical and Yeast extract
from Difco Laboratories, Detriot, Michigan.
The radioactive chemicals - [^®S]-methionine and [^H]-thymidine were
purchased from Amersham Life Science and o-[^^P]-dCTP was bought from Du
Pont NEN Research Products, Boston, MA. The scintillation fluid was
purchased from Amersham Life Science. Scintillation vials were purchased
from Beckman Instruments, Schaumburg, IL.
Methods
Maintenance of Cell Culture:
Primate vascular smooth muscle cells (SMC) were subcultured and
maintained in Dulbecco's Modified Eagle's medium (DMEM), supplemented
with 10% fetal bovine serum (FBS), 200 mM L-glutamine, glucose, lx
streptomycin antibiotics and incubated at 37°C in a 5% CO2 humidified
atmosphere (Ross, 1971; Burke and Ross, 1977).
Isolation of Galaptin mRNA:
The recombinant and control SMC were harvested and washed three
times with sterilized PBS, pH 7.5., 4.0 ml of GIT buffer (4.0 M guanidine iso¬
thiocyanate, 3.0 M sodium acetate, pH 6.0, 0.835% S-mercaptoethanol) was
added to the final pellet and vortexed for 1-2 min (Chirgwin, 1979 and
Carmichael, 1980). These cells were lysed by forcing them 5-6 times through
a 20 gauge needle attached to a 10 cc syringe. The sheared cells were
layered on top of 3.0 ml of CsCI buffer (5.7 M cesium chloride, 3.0 M sodium
acetate) in ultracentrifuge tubes, and centrifuged overnight at 175,000 xg and
20°C in SW 40 Ti Beckman swinging bucket rotors. The RNA was pelleted at
the bottom while galaptin protein settled on top and DNA formed a ring at the
middle. The pelleted total RNA was resuspended in 1.3 ml binding buffer.
One oligo (dT) cellulose tablet was added to the resuspeded total RNA and
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mixed by vortexing. The supernatant was aspirated and centrifuged at 2,000
xg for 10 min at 4“C. The mRNA pelleted was resuspended in 360 ij\ of DEPC
H2O followed by addition of 40 yul of 3.0 M of sodium acetate, pH 6.0.
Finally, the mRNA was precipitated with 1.0 ml of 95% ethanol and stored in
a-70°C.
Synthesis of Specific Galaptin Primers:
Based on the published nucleotide sequence of rat lung galaptin (Clerch
et. al., 1988 and Hirabayashi et al., 1988), we synthesized both galaptin 5'
and 3' end oligonucleotide primers (20 mers) using the phosphoramidite
chemistry (Zucker, 1981; Beacucage, 1981 and Pallansch, 1990). These
primers were synthesized by Clark Atlanta University Molecular Biology
Research Laboratory. The synthesized primers were as follows:
5' primer - 5'-GGGTCAATCATGGCCTGTGGTCTGGTC- 3',
3' primer - 5'-CTAGCTCACTCAAAGGCCACACATTAATC 3'
The synthetic oligonucleotide primers were purified using a cartridge technique
(Zucker, 1981). They were used for synthesis and amplification of galaptin
antisense cDNA by polymerase chain reaction (PCR).
Polymerase Chain Reaction:
The synthesized galaptin cDNA was amplified by the conventional
Polymerase Chain Reaction (Saiki, 1985 and 1988; Mullis, 1986, and 1987)
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using specific galaptin primers. The PCR incubation mixtures (50 //I) contained
10 ng DNA, 1 //M 3'and 5' end primers, 10 mM Tris-HCI (pH 8.3), 50 mM KCI,
2.5 mM MgClj, 170 //g/ml BSA, 200 jjM of dNTP's (dATP, dCTP, dGTP,
dTTP), and 0.25 unit of Taq Polymerase. It was overlaid with 25 //I mineral
oil to prevent evaporation. The PCR mixture was placed in the Precision
Thermal Cycler and amplified through 35 cycles using three temperature
conditions: denaturation at 92°C for 1.0 min, annealing at 56°C for 1.0 min
and extension at 72°C for 1.0 min. Each sample was extracted with
chloroform/isoamyl alcohol (24:1, vol/vol). The PCR products were
precipitated with 100% ethanol. Each sample was analyzed by 1.0% agarose
gel electrophoresis and stained with ethidium bromide. The ethidium bromide
stained gel was visualized via ultraviolet light illumination.
Preparation of Recombinant Gene for Transfection:
The vector used in these studies was pEBVHis that belongs to a family
of EBV vectors. This is a hygromycin resistant episomal vector that has a
Rous sarcoma virus (RSV) 3' long terminal repeat (LTR) and multiple cloning
sites in opposite orientations for high level expression of sense and antisense
transcripts. The multiple cloning sites are fused to the N-terminal peptide of
histidine for purification and characterization of the gene(s) of interest. The
galaptin cDNA was cloned in the Hind III and Sma I of the multiple cloning
sites of this vector directionally using an oligodeoxyribonucleotide adapter.
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Directionality was achieved by creating a Hind III site at the 3' end and Sma
I site at the 5' end of galaptin cDNA insert. The ends of the cDNA inserts
were linked with oligos (GCTT) to generate Hind III sites (AAGCTT) at the 3'
ends of all cDNAs derived from poly(A)^ mRNAs. This was followed by
digestion of the cDNA with Hind III restriction enzyme generating Hind III
cohesive end at the cDNA 3' end::oligo adapter junction. The digested cDNA
and vector were ligated together by T4 DNA ligase.
Preparation and Transformation of E. co/i Cells
The bacterial strains used for transformation were TopIO £. coii. The
Top-10 strains were streaked on a LB media plate (without ampicillin) and
incubated at 37°C on 5% COj for 24 hr (Ausubel et. al. 1991). A single
colony was picked and transferred into 100 ml of SOB media in a one liter
flask, and incubated for 12 hr at 37°C while being shaken at approximately
225 cycles/min In a rotary shaking incubator. When the Agoo of the bacterial
culture reached approximately 0.5, the cells were collected by centrifugation
at 4000 rpm at 4°C for 10 min. The pelleted cells were resuspended in 10 ml
ice-cold 50 mM CaCIs and incubated on ice for 30 min. The CaClj treated cells
were centrifuged at 4000 rpm at 4°C for 5 min. The centrifuged cells are
resuspended in 4 ml of ice-cold 50 mM CaClj and 100 fA of cells were
aliquoted into pre-chilled Falcon 2059 tubes for each transformation, followed
by addition of transforming galaptin cDNA (20 ng). The content of the tube
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was incubated on ice for 30 min, heat shocked at 42°C for 45 sec, then
returned to the ice bath for an additional 2 min. SOC media (1.0 ml) was
added and the culture incubated in 5% COj incubator for 45 min at 37°C with
vigorous shaking. The transformed cells were plated on SOB plates containing
ampicillin (50 /yl/ml) and incubated at 37°C for 24 hr.
Transfection of Vascular Smooth Muscle Cell Line:
The SMC were seeded at 2 x 10® cells in T-25 cm^ flasks and incubated
for 24 hr at 37°C in a humidified COj incubator. The medium was replaced 3-
4 hr prior to transfection. Eighteen //I of 2 M CaClj were added to 10 //g
galaptin cDNA and diluted to a final volume of 150 ij\ with sterile HjO. The
above content was added to a tube containing 150 /y| of 2x hepes buffered
saline pH 7.1, forming a white precipitate. The precipitate was filtered and the
filtrate added dropwise through the medium to the cells in a T-25 cm^ flask.
After mixing the contents of the flask by gentle rocking, the vascular SMC
were incubated for 24 h at 37°C in a humidified COj incubator (Graham and
van der Ebb, 1973).
Selection of Stable Transformants with Hygromycin:
The transfected cells were maintained in non-selective medium for 48
hr post-transfection (Frost and William, 1978). The non-selective medium was
removed and replaced with medium containing hygromycin (200//g/ml). The
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selection was maintained for 2 weeks, changing the medium every 48 hr until
the dead cells were eliminated. The medium was removed and the cells
washed twice with PBS, pH 7.4. This was followed by harvesting the cells by
treatment with trypsin-EDTA. Medium containing 10% FBS was added to
inactivate the trypsin. The cells were replated in four T-75 cm^ flasks in
medium without hygromycin and allowed to attach. The medium was removed
and replaced with selective medium. After forming a confluent monolayer,
frozen stocks were stored at a -185°C (Goedded, 1991).
Extraction of Plasmids DNA from Transfected Vascular Smooth Muscle
Cells:
One confluent T-150 flask of transfected cells was washed two times
with PBS, pH 7.4. A rubber policeman (cell scraper) was used to scrape the
cells gently off the bottom of the plate (Wigler, 1977 and Zhou, 1990). The
cells were collected by centrifugation in a microcentirfuge at 1500 rpm for 5
min. The pellet of cells was resuspended in 100 //I of TE buffer (10 mM Tris-
HCI, pH 7.5 and 1.0 mM EDTA) and incubated on ice for 5 min. An aliquot
(200 //I) of freshly made 0.2 N NaOH, containing 0.1% SDS was added to the
cell preparation and incubation on ice continued for an additional 5 min. At the
end of this second 5 min incubation, 150 //I of 3 M sodium acetate was added
to the mixture and incubation on ice continued for another 5 min. The mixture
was centrifuged for 5 min at 1500 rpm, and the supernatant solution placed
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in a clean tube. To this supernatant solution, 20 ng/ml of RNase A was added
to the mixture and incubated for 30 min at 37°C. Plasmid DNA was extracted
by equal volume of phenol-chloroform, and precipitated with 1.0 ml of ice-cold
100% ethanol. The precipitate was air dried and resuspended in 40 //I of
sterile water.
Isolation of Plasmid DNA from Bacteria by Alkaline Lysis:
The cloned bacteria cells were grown in 3.0 ml of LB-broth (with
hygromycin antibiotic) medium at 37°C overnight in a rotary shaking incubator
(Ausubel, 1991). The cells were collected by centrifugation at 1500 rpm for
5 min and resuspended in 300 //I of TENS solution (10 mM Tris-HCI, pH 7.5;
1.0 mM EDTA; 0.1 N NaOH; 0.5% SDS) and the contents were mixed by
vortexing. To the resuspended cells, 150 //I of 3.0 M sodium acetate, pH 5.2,
were added and vortex mixed to homogeneity, centrifuged for 2 min at 1500
rpm and the supernatant transferred to a fresh tube. Plasmid DNA was
precipitated with 1.0 ml of ice-cold 100% ethanol, then washed twice with
70% ethanol and resuspended in 50 //I of sterile water (Maniatas, 1989).
Partial Digestion of DNA with Restriction Endonucleases:
The original construct, plasmid DNAs isolated from bacteria and vascular
SMC was analyzed by partial digestion with Hind III and Sma I restriction
endonucleases. A mixture of 20.0 fj\ of DNA (10 in TE buffer), 8.0 //I of
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10X restriction enzyme buffer and 12.0 //I of water was placed in a clean
microcentrifuge tube and placed on ice. After mixing, 5.0//I of each restriction
enzyme (Hind III and Sma I) were added to the reaction mixture and the entire
sample incubated for 4 hr at 37°C. The reaction (endonuclease activity) was
stopped by adding 5 //I gel loading buffer, and 10.0 //I of each digested DNA
was analyzed on a 1 % agarose gel, which was then stained with ethidium
bromide and photographed. In principle, 1 unit restriction endonuclease
completely digests 1.0 //g of purified DNA in 60 min using the above
experimental condition.
Cell Proliferation Analysis:
The transfected and control SMC were plated at 1 x 10® cells per well
in triplicate using six well plates and incubated for 24 hr with filtered 10% FBS
medium. The cell cultures were synchronized by growing in a medium
containing filtered 0.5% FBS for 24 hr. Galaptin expression was induced with
0.1 //M Dex and viable cell numbers were measured 12, 24 and 48 hr later.
First, the seeded cells were washed three times with HBSS and detached by
trypsinization with 0.15% trypsin-EDTA. Subsequently, cell were stained with
0.4% trypan blue and triplicate viable cell counting was performed using a
hemocytometer (Hirabayashi and Kasai, 1988 and Sanford and Harris-Hooker,
1990).
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Determination of [^H]-Thymidine Incorporation into Total DNA:
Transfected and control SMC were plated at 1 x 10® cells per well in
triplicate using six well plates and incubated at 37°C in 5% CO2 humidified
incubator for 24 hr (Sanford and Harris-Hooker, 1990). The 10% FBS medium
was replaced with medium containing filtered 0.5% FBS. After 24 hr, galaptin
expression was induced by addition of 0.1 /yM Dex to each well. The cells
were labeled by immediate addition of 0.1 //Ci/ml of [^H]-thymidine for 12, 24
and 48 hr, respectively. The media containing the cells were removed and the
collected cells washed two times with Hank's balanced salt solution (HBSS).
Additional washings {2X) were performed using phosphate buffered saline
(PBS), pH 7.4. Then, labelled DNA was extracted using 1.0 ml of cold 5%
trichloroacetic acid (TCA) for each well. The radioactivity in the TCA soluble
and insoluble fractions was determined by scintillation counting using the
Beckman LS model 500TA (Sanford and Harris-Hooker, 1986).
Formaldehyde RNA Gel Electrophoresis:
The isolated RNA was analyzed using 1.2% formaldehyde agarose gel
electrophoresis. Agarose was weighed and suspended in H2O, heated to
dissolve the agarose, and poured onto the agarose gel apparatus (Wicks,
1986). The casted gel was allowed to solidify for 20-30 min. About 5 //g of
the purified mRNA were mixed with tracking dye and loaded on each well of
the solidified gel. The gel was electrophoresed for 2-4 hr at 60 volts. It was
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stained with ethidium bromide, visualized with an ultraviolet transilluminator
box and finally photographed.
RNA Slot Blot Analysis:
The total RNA from each cell culture was isolated using the cessium
chloride/guanidine thiocyanate gradient centrifugation method, followed by
purification of mRNA on a poly (A)^ column. Slot blot analysis was performed
according to the modified methods of Gillespie, 1984 and Meinkoth, 1984.
From each cell culture, 20 //g of mRNA were serially diluted in six
microcentrifuge tubes. Tube #1 had 130 //I RNase-free 15X SSC solution
while tube #2 to #5 each had 75 //I RNase-free 15X SSC. The RNA samples
were placed in tube #1 and mixed thoroughly, then 75 //I were withdrawn and
placed in tube #2. The serial dilution was repeated up to tube #5. The nylon
membrane was cut, installed into BRL HYBRI-SLOT™ apparatus, the power
vacuum turned on, and 50 fj\ of each sample were applied to its marked slot.
After the power vacuum was off, the membrane was air dried and cross-linked
for 60 sec in the Stratagene UV Cross Linker. The pre-hybridization,
hybridization and autoradiograph methods were similar to that of Northern
blotting. The nylon membrane containing the mRNA was placed in a
hybridization bag and pre-hybridized for 6 hr at 42°C with shaking. The pre¬
hybridization buffer was replaced with 10 ml of hybridization buffer, 50 //I of
l^^Pl-galaptin cDNA probe and incubated for 24 hr at 42°C with shaking. The
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hybridization bag was cut open, drained and the nylon membrane washed for
30 min with 2X SSC buffer containing 0.1 % SDS at room temperature. It was
washed for an additional 15 min with 0.1X SSC buffer containing 0.1 % SDS.
The membrane was placed in plastic wrap to prevent drying and taped in place
in the autoradiographic cassette. An x-ray film was sandwiched between the
intensifying screen and membrane and placed in a -70°C freezer for 24 hr. The
x-ray film was taken out and developed in the automated developer in the
dark.
Northern Blot Analysis:
Northern blotting was performed according to the method developed by
Thomas In 1980. First, total RNA was extracted from each of cultures using
the cesium chloride/guanidine thiocyanate gradient centrifugation method, it
was denatured on a 1% agarose gel containing 16.2 ml of formaldehyde and
transferred overnight to a hybond nylon membrane using 20X saline and
sodium citrate (SSC) buffer. The nylon membrane was dried and cross-linked
for 60 sec in a Stratagene UV Cross Linker, placed in a hybridization bag and
pre-hybridized for 6 hr at 42°C with shaking. The pre-hybridization buffer was
replaced by 10 ml hybridization buffer, 50//I of [^^P]-galaptin cDNA probe and
incubated for 24 hr at 42°C with shaking. The nylon membrane containing the
RNA samples was removed from the hybridization bag and washed for 30 min
with 2X SSC buffer containing 0.1 % SDS at room temperature. It was then
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washed for an additional 15 min with 0.1X SSC buffer containing 0.1 % SDS.
The nylon membrane was placed in saran wrap to prevent drying and taped in
place in an autoradiographic cassette. A x-ray film was sandwiched between
the intensifying screen and membrane and placed in a -70°C freezer for 24 hr.
The x-ray film was taken out and developed in the dark using an automated
developer.
Determination of Protein Concentration:
Total protein content in each cell culture was determined using the
Coomassie Plus standard assay method developed by Sedmak, 1977 and
modified by Marcart, 1982. First, we prepared a known protein standard by
diluting a stock bovine serum albumin (BSA) solution from 75 to 1500 //g/ml.
Tree ml of protein assay solution were added to each of the protein samples
and serially diluted standard protein solutions. The samples and protein assay
solution were thoroughfully mixed and left to stand at room temperature for
15 min. The absorbance for each sample and protein standards were read at
595 nm. All samples were assayed in triplicates. A standard curve was
prepared by plotting the average absorbance for each diluted protein standard
against the concentration of each protein standard. This curve was used to
determine the total protein concentration of each sample. Galaptin was




Isolated proteins from recombinant and control cell cultures were
subjected to 15% SDS-Polyacrylamide gel electrophoresis (Laemmli, 1970).
Cells (5x10®) were harvested with trypsin-EDTA and washed three times with
PBS, pH 7,4. After centrifugation, the pelleted cells were lysed with 600 ij\
lysis buffer containing 50 mM HEPES (pH 7.0), 250 mM NaCI, 1.0% Triton X-
100 and 0.1% NP-40. Protein precipitation solution (200 //I) was added to
the cell lysate and uniformly mixed by high speed vortexing. Proteins were
pelleted at 13,000 xg for 5 min and resuspended in 200 /yl of PBS (pH 7.4).
From each sample, 40 ;yg of protein were boiled in Laemmli sample buffer at
100°C for 5 min, loaded on each well and electrophoresed on 15% SDS-PAGE
at 8 milliamps for 9 hr or until the tracking dye reached the bottom of the gel.
The gel was stained with Silver Stain Plus from BioRad Laboratories and
scanned on the densitometer.
Immunoblotting of Galaptin:
Galaptin expressed by the recombinant and control culture cells were
analyzed by using Enhanced Chemiluminescence (ECL) immunoblotting
method. Galaptin was serially diluted and spotted on the nitrocellulose
membrane with slot blot equipment. The non-specific binding sites on the
membrane were blocked by immersing in 5% blocking agent (dried milk) in
phosphate buffered saline-Tween 20 (PBS-T) at room temperature for 1.0 hr.
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The membrane was rinsed twice with PBS-T at room temperature for 15 min.
The membrane was incubated with anti-lectin (1:100) at room temperature for
2.0 hr. Again, the membrane was washed twice with PBS-T at room
temperature for 15 min, and then incubated with anti-goat IgG (1:200) at 4°C
for 2.0 hr followed by washings with PBS-T for two 15 min periods. Finally,
the detection solution was poured over the membrane after a 1.0 min
incubation. The membrane was placed in a cassette, autoradiographed for 1.0
min and developed in an automated developer.
Metabolic Labeling and Immunoprecipitation of Galaptin:
Both recombinant and control (5 x 10®) cells were plated in T-25 cm^
culture flasks and incubated at 37°C in Dulbecco's Modified Eagle's Medium
(DMEM) containing 10% fetal bovine serum (FBS) and lx antibiotics. After 24
h, the cultured cells were washed three times with Hanks balanced salt
solution (HBSS), and synchronized for 48 hr with filtered 0.5% FBS-free
medium. The cultured cells were incubated for 2 hr in a solution containing 5
ml of methionine, cysteine and FBS-free medium and 50 //Ci/ml [^®S]-
methionine (Austin and Pollard, 1986). The medium was drained off and the
cultured cells in the flask washed with phosphate buffered saline (PBS). The
cells were harvested with trypsin, washed with PBS and lysed with 1.0 ml of
lysis buffer (150 mM NaCI, 1% NP-40, 0.5% DOC, 0.1% SDS and 50 mM
Tris, pH 7.5). The lysed cells were incubated on ice for 30 min with
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occasional rocking and then centrifuged at 10,000 xg for 10 min at 4°C. The
lysates were incubated with 1:200 anti-galaptin antisera for 16 hr at 4°C and
centrifuged to remove the antibody from the solution. The labeled galaptin
was analyzed by SDS-polyacrylamide gel electrophoresis and glass fiber filter
spotting. The electrophoresed gel was fixed for 1 hr in 5% methanol and 10%
acetic acid, dried and autoradiographed at a -70°C for 24 hr (Morley, 1985 and
Clemens, 1984).
Determination of Rate of [^®S]-Methionine Incorporation into Galaptin:
The precipitated galaptin (5 //I) was mixed with 5 //I of 10 mg/ml of BSA
and applied to the center of dry filter membranes (1 inch in diameter) that were
placed in petri dishes. The filters were flooded with ice-cold 10%
trichloroacetic acid (TCA) and then incubated on ice at 4°C for 30 min. The
TCA was replaced with fresh 10% TCA and incubated for 5 min with shaking
at room temperature. Two more incubations at room temperature for 5 min
were performed. These filters were washed with 95% ethanol and allowed to
air dry on a sheet of aluminum foil under infrared light. The air-dried filters
were placed in counting vials containing scintillation liquid and the




The cell adhesion assay was a modification of Klebe (1974) and
Aumailley (1989) methods. First, stock solutions of laminin and ECL-matrix
proteins (1 mg/ml PBS, pH 7.4) were prepared and 1.0 ml from each stock
was mixed with 9 ml of 2% gelatin and sufficient mixture was pipetted into
12-well cell culture plates. The protein solution was allowed to stand at room
temperature for 5 min. The coated plates were then rinsed two times with
PBS and allowed to air dry under a sterilized environment before being stored
at -20°C until ready to be used. Cells (1 x 10®) were added to each coated
well in the presence and/or absence of galaptin. The cells were allowed to
adhere to the coated plates by incubation at 37°C in a humidified 5% COj
atmosphere. Each well was washed three times with PBS, pH 7.4 to remove
unattached cells at 2, 4 and 6 hr of incubation. After trypsinization with
trypsin-EDTA, adhered cells were counted on the hemocytometer. Data are
represented as mean ± standard error of the mean (SEM).
Cell Migration Analysis:
A videomicroscopic image system was used to record the rate and total
distance traveled by the recombinant and control cultures over a period of 4
hr. In order to determine the rate of migration, cells were sparsely (1 x 10®)
seeded in T-25 cm^ flasks and incubated for 24 hr at 37°C in a 5% COj
humidified incubator. Each flask was sealed tightly and placed on the stage
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of a Leitz Labovert microscope that was maintained at 37°C using an air
current incubator. The microscope was connected to a Panasonic AG-6050
time-lapse video recorder (set for a compression time of 480x) and a high
resolution Panasonic WV 5410 monitor. The images that appeared on the
monitor were collected with a special video camera and stored on a regular
VHS video tape using a Panasonic VCR. The rates of migration for the
recorded images in the presence and/or absence of Dex were analyzed on 20x
magnification using the Optimas (version 2.0) image processor program stored
on the Compaq IBM-compatible computer. About 20 to 30 cells were
monitored for each culture over a period of 4 hr. The rate of migration is
defined as the average distance traveled per cell per unit time based on 15 to
30 cells being monitored in each culture.
To determine the total migration, each cell culture was grown to
confluency in a T-25 cm^ flask. Then, an area of each cell culture was denuded
with a custom-made cell scraper. Next, the cultures were induced with 0.1
jjM Dex for 2 hr before being placed on the microscopic stage. The total
migration for each culture was recorded over a period of 4 hr and analyzed
using the Optimas image processor program. Total migration is defined as
average of distance traveled per cell based on the average of 15 to 30 cells
monitored in each cell culture.
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Scanning Electron Microscopic Analysis of Cell Morphology:
Scanning electron microscopy (SEM) was used to study the
morphological changes and membrane activities after transfection of ceils with
recombinant galaptin. Both recombinant and control cells were grown to
confluency in T-25 cm^ flasks and primarily fixed with histochoice tissue
fixative solution and 2.5% glutaraldehyde for 3 hr. The samples were washed
two times with 0.1 M cacodylate buffer, pH 7.4 for 10 min and secondarily
fixed in 1 % osmium tetroxide (O2O4) for 1 hr. Again, the fixed samples were
washed two times with 0.1 M cacodylate buffer for 10 min. Fixation with
primary and secondary fixatives helped preserve the structural integrity and
morphology of samples. The samples were next dehydrated in an increasing
series of alcohol solution: 30, 50, 70, 95 and 100%, respectively. Each of the
dehydration steps lasted for 5 min. These steps remove water (liquid medium)
and substitute ethanol which is miscible with the transitional medium of liquid
carbon dioxide contained in the critical point machine (CPM). This is followed
by drying the samples in the critical point machine for approximately 45 min.
This step removed liquid CO2 and dried samples without shrinkage and
morphological distortion. In reality, approximately 8% shrinking may occur
compared to 60-70% shrinking when dried at room temperature. The sputter
coater machine was used to coat samples with a 10-20 nm layer of
gold/palladium (Au/Pd). This step provide amplified 2° electron signals in the
microscope for viewing. Also, coating protects the sample from overheating
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and disintegration under the electron beam with voltage of 10 kV or more.
The samples were viewed with the scanning electron microscope (JSM 820
Model, Jeol Co.) at magnifications of 250X, 1000X and 2500X and pictures
taken with Polaroid PRH Camera.
Presentation of Data:
In these studies, data were presented as averages ± standard error of
the means (SEM). We determined statistical significance by one way analysis
of variance (ANOVA) and Scheffe's multiple comparison methods.
CHAPTER IV
EXPERIMENTAL RESULTS
Synthesis of Galaptin cDNA;
We synthesized 450 bp galaptin cDNA using the mRNA isolated from
Vascular Smooth Muscle cells (SMC). The cDNA was amplified by the
conventional method. Reverse Transcription Polymerase Chain Reaction (RT-
PCR) using galaptin specific primers and Taq DNA Polymerase. The primers
were:
5' primer - 5'-GGGTCAATCATGGCCTGTGGTCTGGTC- 3',
3' primer - 5'-CTAGCTCACTCAAAGGCCACACATTAATC 3'
An Sma I site was placed at the 5' end of the N-terminal primer and a Hind III
site was included at the 3' end of the C-terminal primer to facilitate cloning of
PCR products. The RT-PCR reaction was carried out as described in the
materials and methods. The products of the PCR were analyzed on 1.0%
agarose gel electrophoresis, Figure 1.
Construction and Cloning of Recombinant Gene:
The construction of galaptin antisense recombinant used in these studies
is outlined in Figure 2. The incorporation of Sma I and Hind III sites at the 5'
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Figure 1. 1 % agarose gel electrophoresis of cDNA transcribed from galaptin
mRNA using galaptin specific primers and Taq Polymerase. Lane 1, molecular
weight marker (1 kb ladder); lane 2, untransfected cells cDNA; lane 3, vector




and 3' ends, respectively, during amplification allows for direct positional
insertion of galaptin cDNA into the pEBVHis vector. Both the cDNA and vector
were digested with Sma I and Hind III restriction enzymes and ligated with T4
DNA ligase, forming the galaptin cDNA recombinant. Note that the cDNA was
inserted in antisense orientation downstream of the pEBVHis vector promoter.
It was cloned into the Top 10 strain of E. coli. We used the pEBVHis vector
because it was specially designed for cloning, transfecting and replicating of
antisense genes (cDNA) in selected eukaryotic cell lines. This vector can also
replicate episomally (extrachromosomally in high copy numbers) in vascular
SMC nuclei because of the presence of viral genes, e.g. EBV nuclear antigen
(EBVNA-I), On P and/or other nucleotide sequences (Milanesi et al., 1984 and
Yates et al., 1985). The presence of the hygromycin gene on this vector
enabled the use of hygromycin as a selectable antibiotic for screening clones
containing galaptin recombinant cDNA that was oriented in the antisense
direction downstream of pEBVHis promoter.
Analysis of Recombinant Gene Before Transfection:
Following cloning and amplification of galaptin antisense cDNA in E. coli,
plasmid was isolated by mini-plasmid preparation (invitrogene kits). Before
transfection of the vascular SMC with the amplified recombinant, the isolated
plasmid was compared to the original constructs by restriction endonuclease
digestion. This was done in order to verify that the isolated plasmid did not
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Figure 2. Schematic representation of galaptin cDNA inserted in antisense
direction. Here, galaptin mRNA was reverse transcribed to cDNA using
galaptin specific primers. Primers containing Hind III {5'-end) and Sma I (3'-
end) sequences were used to amplified the galaptin cDNA by RT-PCR, digested
with the same restriction enzymes and ligated into the pEBVHis (10.3 kb)
vector using T4 ligase. The galaptin gene was driven by the simian virus 40














Amplified by PCR, digested with
same restriction enzymes and
ligated with T4 ligase.
Galaptin cDNA
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mutate (change its sequences) when cloned in £. coH. The original and
isolated plasmids from both E. coli and transfected vascular SMC were
digested with Sma I and Hind III restriction enzymes. All exhibited similar
migration patterns on the 1.0% agarose gel. The bands on the gel were 10.3
kb, corresponding to the size of the pEBVHis vector, and 0.45 kb,
corresponding to the size of inserted galaptin cDNA (Figures 3 and 4).
Transfection of Recombinant Gene into Vascular Smooth Muscle Cells:
The recombinant containing galaptin cDNA which was oriented in the
antisense direction and pEBVHis vector were transfected into vascular smooth
muscle cells via the calcium phosphate precipitation method. The clones were
selected by culture in hygromycin for 14 days. Initially, 11 resistant clones
were picked from the parent (general population) recombinant culture. All
clones selected exhibited similar cellular and biochemical activities as the
parent culture. The incubation of the parent and selected clones with Dex for
48 hr resulted in decreases in such functions as cell adhesion and migration.
However, as expected vascular SMC transfected with pEBVHis vector alone
behaved similarly in all tested assays as did untransfected SMC after 12, 24
and 48 hr of Dex treatment.
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Figure 3. 1 % agarose gel electrophoresis of plasmids isolated from vascular
SMC and bacterial cells before partial digestion with restriction endonucleases.
Lane 1, original construct; lane 2, plasmid from vascular SMC and lane 3,
plasmid from bacterial cells.
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Figure 4. Restriction endonuclease digestion of original recombinant galaptin
gene construct and isolated plasmids from vascular SMC and bacterial cells.
Plasmids containing galaptin gene were digested with Hind III and Sma I for 4
hr at 37°C. Digested plasmids were analyzed on 1.0% agarose gel and stained
with ethidium bromide. Lane 1, molecular weight marker (1 kb ladder); lane
2, plasmid from original construct; lanes 3 and 4, plasmids from SMC clones
and lane 5, plasmid from bacterial cell.
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Effect of Transfection on the Expression of Galaptin mRNA:
To determine whether the antisense recombinant reduced the level of
galaptin mRNA, the mRNA from recombinant, selected clones and control
cultures was analyzed by slot blotting using a specific galaptin cDNA probe.
First, each culture was plated for 24 hr in medium containing 10% FBS. The
10% FBS medium was replaced with filtered 0.5% FBS medium in order to
synchronize the culture, which was induced with 0.1 //M Dex for 48 hr. Total
RNA from the recombinant and control cultures was isolated by the cesium
chloride/guanidine thiocyanate gradient method. Galaptin mRNA was purified
using a poly (A)^ column. In the slot blotting, mRNA was serially diluted and
spotted onto the nylon membrane. The membrane was hybridized with
galaptin cDNA as a specific probe and autoradiographed for 24 hr at a -70°C.
In slot blotting, no differences were detected in the expression of mRNA in the
recombinant culture when compared to the control cultures. As can be seen
in Figure 5, the recombinant cells transcribed galaptin messages in a manner
similar to that of control cells. This suggests that the recombinant gene has
no effect on the transcriptional process.
The expression of galaptin mRNA in the recombinant and control cells
was also analyzed by Northern blotting after 48 hr (Figures 6 and 7). Galaptin
mRNA was detected in the control and recombinant cell cultures. The size of
galaptin transcripts in the clones were 280 and 400 base pairs which was
consistent with the predicted size for the galaptin transcripts produced using
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Figure 5. Slot blotting of mRNA isolated from recombinant and control cells.
The mRNA was spotted onto a nylon membrane and probed with galaptin
cDNA probe that was labeled with [^^P]-dCTP. Lane 1, untransfected cells
RNA without Dex; lane 2, untransfected cells RNA with Dex; lane 3, vector
transfected cells RNA without Dex; lane 4, vector transfected cells RNA with




pEBVHis vector. The galaptin cDNA probe was stripped from the nylon
membrane and re-probed with a control actin probe. The mRNA of both the
control and recombinant cells hybridized to the actin probe (Figure 8). These
results indicate that the level of accumulation of galaptin mRNA was similar in
both the recombinant and control cultures, suggesting that accumulation of
mRNA was generally independent of nuclear expression.
Effect of Transfection on the Expression of Galaptin and Total Protein:
These experiments were designed to determine if the steady-state levels
of total RNA In both recombinant and controls Impacted on the expression of
galaptin and total protein. Harvested cells were lysed with lysis solution. The
total protein and the amount of [^H]-thymidine incorporation into the total DNA
were determined and these two values were correlated for purposes of
comparison between the recombinant and control cells in the presence and/ or
absence of Dex. This was done in order to off-set the number of recombinant
cells following treatment with Dex. As shown in Table 1, the recombinant
cells that were induced with Dex for 48 hr yielded 0.046 //g/ml protein/pH]-
Thymidine of total DNA. The untransfected cells upon treatment with Dex
yielded 0.053 ///ml protein/[^H]-Thymidine of total DNA and vector transfected
cells yielded 0.052 //g/ml protein/pH]-Thymidine of total DNA. Similar results
were seen in the uninduced cell cultures. The observed values in the Dex
induced and uninduced cultures were not statistically different. These results
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Figure 6. Agarose gel electrophoresis of mRNA isolated from cells before
being transferred to nylon membrane and probed with galaptin cDNA and
control actin probes. Lane 1, untransfected cells RNA without Dex; lane 2,
untransfected cells RNA with Dex; lane 3, vector transfected cells RNA
without Dex; lane 4, vector transfected cells RNA with Dex; lane 5,




Figure 11. Immunoblot analysis of the expressed and purified galaptin using
polyclonal anti-galaptin. Lane 1, untransfected cells without Dex; lane 2,
untransfected cells induced with Dex; lane 3, vector transfected cells induced





Figure 10. Densitometric scanning of the galaptin (14.5 kDa) bands from the




Figure 9. 15% SDS-Polyacrylamide gel electrophoresis of expressed galaptin
from cells that were induced with Dex for 48 hr. Lanes 1, untransfected cells;
lane 2, vector transfected cells; and lane 3, recombinant cells. See methods
and materials for experimental procedure.
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Table 1. Total protein contents from the recombinant and control cells
that were induced with 0.1 //M/ml for 48 hr.
Cell Treatment
/yg/ml Total Protein/[^H]-Thymidine Total DNA
Absence of Dex Presence of Dex
Recombinant 0.049 0.046
Untransfected 0.048 0.053
Vector Transfected 0.042 0.052
Values are mean ± standard error of the mean (sem).
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demonstrate that overall total protein synthesis was not inhibited or altered in
the Dex induced and uninduced cell cultures after 48 hr. But, in the presence
of Dex, the amount of galaptin from the recombinant culture was reduced by
approximately 50-55%, as shown in Figure 9, Densitometric scanning of the
bands from the SDS-PAGE corresponding to the 14.5 kDa showed a 55%
reduction in galaptin in the recombinant cell culture compared to the controls
(Figure 10). This reduction was observed only when recombinant and control
cultures were induced with Dex. Again, this demonstrates that the significant
reduction of galaptin synthesis in the recombinant culture was due to a
specific inhibition of galaptin expression.
Not only were the amounts of galaptin synthesized by recombinant and
control cells assessed by 15% SDS-polyacrylamide gel electrophoresis, but
immunoblotting was performed on the extracted proteins using antibodies
generated against galaptin. Proteins were serially diluted and spotted on
nitrocellulose membrane, blocked with 10% BSA and washed with PBS (pH
7.4). The membrane was probed with polyclonal anti-galaptin using ECL kits.
We observed that Dex recombinant cells exposed to Dex for 48 hr showed an
approximate 50% decrease in galaptin expression when compared to the
control cells (Figure 11).
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Figure 8. Northern blotting of mRNA isolated from recombinant and control
cells. The galaptin cDNA probe was striped off nylon membrane and re-probed
with a control actin probe that was labeled with [^^P]-dCTP. Lane 1,
untransfected cells RNA without Dex; lane 2, untransfected cells RNA with
Dex; lane 3, vector transfected cells RNA without Dex; lane 4, vector
transfected cells RNA with Dex; lane 5, recombinant cells RNA without and
lane 6, recombinant cells RNA with Dex.
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Figure 7. Northern blotting of mRNA isolated from recombinant and control
cells. First, mRNA was analyzed on a 1 % agarose gel, transferred to nylon
membrane and probed with galaptin cDNA probe that was labeled with [^^P]-
dCTP. Lane 1, untransfected cells RNA without Dex; lane 2, untransfected
cells RNA with Dex; lane 3, vector transfected cells RNA without Dex; lane 4,
vector transfected cells RNA with Dex; lane 5, recombinant cells RNA without
Dex and lane 6, recombinant cells RNA with Dex.
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Metabolic Labeling of Galaptin with pS]-Methionine Trans-Labeling Kit:
To determine whether translation might be the post-transcriptional event
that regulates the synthesis of galaptin, SMC were metabolically labeled
overnight with [^®S]-methionine trans-labeling kits in the presence and absence
of Dex. The cells were harvested and lysed with lysis buffer containing 50
mM HEPES (pH 7.0), 250 mM NaCI and 0.1% NP-40. The lysate was
incubated with anti-galaptin antibody for 24 hr at 4°C. Following extensive
washing with PBS (pH 7.4), the galaptin-immune complex was incubated on
ice for 30 min. The separated eluates from the complex were analyzed on
15% SDS-PAGE and autoradiographed. The autoradiograph showed a
migration pattern with a 14.5 kDa band in the control cells. This migration
pattern was similar to that seen in 15% SDS-PAGE analyses of galaptin
isolated from unlabeled cells. This band was absent or less visible in the Dex
treated recombinant cell culture. The results are shown in Figure 12. Again,
this demonstrates that the recombinant gene is inhibiting the translation of the
galaptin gene.
Determination of Rate of Incorporation of P®S]-Methionine into Galaptin:
Next, the rate of labeling of galaptin in each cell culture was determined
in the presence and absence of Dex. Each cell lysate (100 ij\) was extracted
with 1.0 ml of cold 5% trichloroacetic acid (TCA) and spotted on 1.0 inch
diameter filter membranes. All membranes were washed three times and
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Figure 12. 15% SDS-Polyacrylamide gel electrophoresis of metabolic labeled
galaptin with Trans [^®S]-methionine in serum free medium for 24 hr. Cells
were harvested, washed, lysed and proteins analyzed on 15% SDS-PAGE.
Lane 1, low molecular weight markers (BioRad); lane 2, recombinant cells
without Dex; lane 3, recombinant cells induced with Dex; lane 4,
untransfected cells without Dex; untransfected cells induced with Dex; lane 5,





scintillation counts were performed in triplicates. The Dex treated recombinant
culture yielded 5,222.73±453 dpm per //g protein compared to the controls
8,854.62 ±753 dpm for untransfected culture and 7,437.01 ±539 dpm for
vector transfected culture. The selected clones, Rec-1 and Rec-3 incorporated
[^®S]-methionine similar to the recombinant parent culture. The differences in
the rate of incorporation of [^®S]-methionine into galaptin observed in the
recombinant and control cells were significant at p < 0.05. In the absence
of Dex, there were no significant differences between the recombinant and
control cultures (Figure 13).
Effect of Transfection on the Vascular Smooth Muscle Cells Proliferation:
To determine if increased galaptin expression correlates with cell growth
(proliferation), 1x10® cell/ml were seeded in six well plates overnight. The
cell cultures were synchronized for 48 hr by replacing 10% FBS medium with
filtered 0.5% FBS medium. The quiescent SMC cultures were induced with
0.1 % Dex and cell proliferation was measured at 12, 24 and 48 hr. At 12, 24
and 48 hr of incubation without Dex, no significant difference in cell
proliferation was observed between the recombinant and control cells (Figure
14). At 12 hr treatment with Dex, the viable cell count was 0.38 ±0.085 x
10® for recombinant culture compared to 0.85 ±0.095 x 10® for untransfected
cells and 0.85 ±0.0063 x 10® for vector transfected cells. At 24 hr, the
recombinant cells induced with Dex proliferated to 0.64 ± 0.05 x 10® compared
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Figure 13. Rate of metabolic labeling of galaptin in recombinant and control
cells labeled with Trans [®®S]-methionine in serum free medium for 24 hr.
Labeled proteins were spotted on circular filter paper, washed with PBS (pH
7.4), precipitated with ice-cold TCA and amount of radioactivity counted on
















Figure 14. Viable cell counts of recombinant and control cells in the absence
of Dex. Cells were seeded in 6 well plates in filtered 0.5% FBS medium,
trypsinized with trypsin-EDTA and counted using hemocytometer at 12, 24











to untransfected cells, 3.08 ±0.041 x 10® and vector transfected cells,
3.15±0.004 X 10®. The cell proliferation was 60% higher in control cells
when compared to the recombinant cells and this is statistically significant at
p-value of 0.01. At 48 hr, Dex induced recombinant cells showed a decreased
cell proliferation of 1.24 ±0.048 x 10® viable cells compared with the
5.25 ±0.026 X 10® for untransfected cells and 5.33 ±0.075 x 10® for vector
transfected. Again, cell proliferation was 60% higher in the control cells when
compared to the recombinant cells and this is statistically significant at p-value
of 0.01. The above results showed about a 50-60% decrease in viable cell
number when recombinant cultures were induced with Dex (Figure 15). This
finding suggest that galaptin is involved in SMC proliferation.
Effect of Transfection on the [®H]-Thymidine Incorporation into Total DNA:
To determine whether the galaptin recombinant gene affect [^H]-
thymidine incorporation into total DNA, 1x10® cell/ml were seeded in six well
plates overnight. The cell cultures were synchronized for 24 hr by replacing
10% FBS media with filtered 0.5% FBS media. Then, 1.0 /yCi of [®H]-
thymidine was added to each well, followed by inducing the cells with 0.1%
Dex. Cells was lysed with lysis buffer. Labeled total DNA was precipitated
with ice-cold 5% TCA and scintillation counts performed in triplicates at 12,
24 and 48 hr, respectively. As shown in Figure 16, there was no significant
difference in the amount of total DNA between the uninduced recombinant and
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Figure 15. Viable cell counts of recombinant and control cells in the presence
of 0.1 jjM Dex. Cells were seeded in 6 well plates in filtered 0.5% FBS
medium, trypsinized with trypsin-EDTA and counted using hemocytometer at









control cells at 12, 24 and 48 hr. Dex stimulation increased total DNA
synthesis in the control cells compared to the recombinant cells. At 12 hr of
Dex stimulation, the [^H]-thymidine incorporation for recombinant cells was
792.2 ±21.1 dpm while untransfected cells was 1,439.2 ± 11.2 dpm and the
amount in vector transfected cells was 1,448.0 ±20.9 dpm. At 24 hr of Dex
treatment, [^H]-thymidine incorporation into the total DNA was 984.1 ±8.3
dpm for recombinant cells compared to 2,165.1 ± 13.9 dpm for untransfected
cells and 2,241.7 ±9.9 dpm for vector transfected cells. After 48 hr of Dex
induction, the amount of [^H]-thymidine incorporation was reduced by
approximately 55-60% compared to the controls (Figure 17). The amount of
I^H]-thymidine incorporated in total DNA by the recombinant cells was
1,095.6 ±25.6 dpm compared to 3,174.4 ± 125.2 dpm for untransfected cells
and 3,190.1 ± 184.5 dpm for vector transfected cells. The observed
difference between the recombinant and control cells at 12, 24 and 24 hr were
statistically significant at p < 0.01. However, there was no significant
difference in [^H]-thymidine incorporation between the uninduced recombinant
and control cultures.
Effect of Transfection on the Vascular Smooth Muscle Cells Motility:
It was of interest to determine if transfection of vascular SMC with the
recombinant gene affected the motility of cells. To address this question,
video imaging methods were used to analyze the rate and total motility of both
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Figure 16. [^H]-thymidine incorporation into total DNA of the recombinant and
control cells in the absence of Dex. Cells were seeded in 6 well plates in
filtered 0.5% FBS medium followed by addition of 0.1 //Ci of [^H]-thymidine.
At 12, 24 and 48 hr, cells were washed, trypsinized with trypsin-EDTA,









Figure 17. [^H]-thymidine incorporation into total DNA of the recombinant and
control cells in the presence of Dex. Cells were seeded in 6 well plates in
filtered 0.5% FBS medium followed by addition of 0.1 /jC\ of [^H]-thymidine.
At 12, 24 and 48 hr, cells were washed, trypsinized with trypsin-EDTA,




the transfected and control cultures. Migration analysis was performed using
sparse and confluent cultures.
First, the rate and distance migrated by the cultured sparse cells were
calculated. Both the recombinant and control cultures were plated at sparse
concentrations of 1 x 10^ cells per T-25 cm^ flask. This allowed the cells to
move for a period of 1 to 24 hr without encountering each other. It was
noticed that sparse cultured cells moved randomly with no particular
directional path. Using time-lapse videomicroscopy and image analysis, the
rate (distance per unit time) and distances traveled by individual cells
(approximately 15 to 30 cells) were tracked for 4 hr. At 4 hr, the recombinant
cells migrated at the rate of 6.54 ±1.13 /;m per hr and a distance of
26.16±4.50 //m in the presence of Dex (Table 2). The rate and distance
migrated by the untransfected control cells were 15.80 ± 1.91 //m per hr and
63.19 ± 7.62 //m and vector transfected cells were 14.56 ± 0.92 //m per hr and
58.25 ±3.68 //m respectively (Table 3). Treatment of cells with Dex resulted
in approximately 50% reduction in the recombinant cells migration (Tables 2
and 3). The observed difference was statistically significant at p < 0.01.
There were no significant differences between uninduced recombinant and
control cells at 4 hr (Tables 2 and 3).
In the second part of the migration analyses, confluent cell cultures that
were denuded with a custome made cell scraper were used. Recombinant and
control cells were cultured to confluency in T-25 cm^ flasks. An area of each
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Table 2. Total Motility of Recombinant and Control Sparse Cells in the










Values are mean ± standard error of the mean. *p < 0.01. n = 15.
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Table 3. Rate of Motility for Recombinant and Control Sparse Cells in
the presence and/or absence of Dex (/[im per hr).
Cell Treatment
Rate of Motility (^/m/hr)
Absence of Dex Presence of Dex
Recombinant 11.43 ±1.56 6.54±1.13*
Untransfected 12.53±1.82 15.80±1.91*
Vector Transfected 10.64 ±1.03 14.56±0.92*
Values are mean ± standard error of the mean. *p < 0.01. n = 15.
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cell culture was denuded with a custome made cell scraper and migration of
cells into the denuded area was monitored for 24 hr. Figure 18 represented
picture taken immediately following denudation of each cultured cells. The
recombinant cells migrated into the denuded area but at a much slower rate
compared to the control cells (Figure 19). The control cells filled the denuded
area in approximately 12-14 hr compared to recombinant cells that filled the
denuded area in approximately 25-28 hr (Figures 20-21).
Video imaging analysis was used to calculate the rate and total distance
migrated traveled by the recombinant and control confluent cell cultures. The
Dex induced recombinant cells migrated at a rate of 8.48 ±1.13 //m per hr and
a distance of 34.49 ±1.37 //m after 4 hr. However, the Dex induced
untransfected cells migrated at a rate of 24.26 ± 0.75 //m per hr and a distance
of 97.03 ±3.00 A/m after 4 hr (Tables 4 and 5). Also, the Dex induced vector
transfected cells migrated at a rate of 21.60 ±1.92 //m per h and a distance
of 86.41 ±7.68 //m after 4 hr (Tables 4 and 5). The observed differences
were statistically significant at p < 0.01. There was no significant difference
in the rate and total distance migrated between the uninduced recombinant
and uninduced control cultured cells. When 5 //g of galaptin was added to the
Dex induced sparsely recombinant and control cultured cells, the rate and total
distant migrated by the recombinant cells increased by approximate 25-30%
compared to the sparsely control cells (Tables 6-7). Similarly, in the presence
of galaptin, the rate and total distance migrated by the confluent recombinant
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cells increased by about 20-30% compared to the confluent control cells
(Tables 8-9). Also, the sheet migration analysis of the confleunt recombinant
and control cultured cells showed that there was 20-30% increase in the rate
and total distance migrated by the recombinant cultured cells (Figure 22).
However, there was no significant increase or decrease in the rate and total
distance migrated by the sparsely seeded and confluent cultured cells (Figures
6-9). The restoration of motility by the recombinant cells is congruent with a
role for galaptin in cell motility. The observed trends for cell migration
behavior were in parallel with trends observed for cell growth, adhesion and
membrane activities.
Effect of Transfection on the Adhesion of Vascular Smooth Muscle Cells:
The cell surface adhesion of vascular SMC was analyzed following
transfection with the galaptin recombinant gene. Twelve well plates coated
with ECL-matrix, laminin and collagen were used to assess the binding to the
substrate of the controls, parental recombinant and two selected clones, Rec-1
and Rec-3. The cells were seeded on plates that were either uncoated or
coated with laminin, ECL-matrix or gelatin. Adhesion of cells to these surfaces
was monitored after 2, 4 and 6 hr. It was observed that the recombinant cells
adhered to the laminin and ECL-matrix coated surfaces at a lower rate than
control cells. At 2 hr, 1.78±0.57 x lO'* recombinant cells bound to the
laminin coated plates compared to 4.39 ±0.13 x 10^ untransfected control
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Table 4. Total Motility of Recombinant and Control Confluent Cells in
the presence and/or absence of Dex after 4 hr.
Cell Treatment
Total Motility (//m)
Absence of Dex Presence of Dex
Recombinant 45.32±3.94 34.49 ±1.37*
Untransfected 47.52 ±3.44 97.03 ±3.00*
Vector Transfected 41.27±1.71 86.41 ±7.68*
Values are mean ± standard error of the mean (sem). *p < 0.01.
n = 14.
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Table 5. Rate of Motility for Recombinant and Control Confluent Cells
in the presence and/or absence of Dex {/mx per hr).
Cell Treatment
Rate of Motility (//m/hr)
Absence of Dex Presence of Dex
Recombinant 12.40 ±0.99 8.48±1.13*
Untransfected 11.88±0.86 24.26±0.75*
Vector Transfected 10.32±0.43 21.60±1.92*
Values are mean ± standard error of the mean (sem). *p < 0.01.
n = 14.
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Figure 18. Sheet migration analyses of recombinant cells compared to
untransfected and vector transfected cells at 0 hr in the presence or absence
of Dex. A and B were untransfected cells with and without Dex; C and D
were vector transfected cells with and without Dex and E and F were
recombinant cells with and without Dex. Cells were cultured to confluency in
T-25 cm^ flasks in filtered 0.5% FBS medium. An area of each culture was
denuded with a custom made cell scraper. The rate and total distance




Figure 19. Sheet migration analyses of recombinant cells compared to
untransfected and vector transfected cells at 6 hr in the presence or absence
of Dex. A and B were untransfected cells with and without Dex; C and D
were vector transfected cells with and without Dex and E and F were
recombinant cells with and without Dex. Cells were cultured to confluency in
T-25 cm^ flasks in filtered 0.5% FBS medium. An area of each culture was
denuded with a custom made cell scraper. The rate and total distance






Figure 20. Sheet migration analyses of recombinant cells compared to
untransfected and vector transfected cells at 12 hr in the presence or absence
of Dex. A and B were untransfected cells with and without Dex; C and D
were vector transfected cells with and without Dex and E and F were
recombinant cells with and without Dex. Cells were cultured to confluency in
T-25 cm^ flasks In filtered 0.5% FBS medium. An area of each culture was
denuded with a custom made cell scraper. The rate and total distance






Figure 21. Sheet migration analyses of recombinant cells compared to
untransfected and vector transfected cells at 18 hr in the presence or absence
of Dex. A and B were untransfected cells with and without Dex; C and D
were vector transfected cells with and without Dex and E and F were
recombinant cells with and without Dex. Cells were cultured to confluency in
T-25 cm^ flask in filtered 0.5% FBS medium. An area of each culture was
denuded with a custom made cell scraper. The rate and total distance
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Figure 22. Sheet migration analyses of recombinant :ells compared to
untransfected and vector transfected cells at 0, 6, 12 and 18 hr in the
presence or absence of 0.1 //g/ml galaptin. A-D were untransfected cells; E-H
were vector transfected cells and l-L were recombinant cells. Cells were
cultured to confluency in T-25 cm^ flasks in filtered 0.5% FBS medium. An
area of each culture was denuded with a custom made cell scraper followed
by addition of 0.1 //g/ml of galaptin. The rate and total distance migrated by






Table 6. Total Motility of Recombinant and Control Sparse Cell
Cultures treated with Dex and galaptin after 4 hr.
Total Motility (jjm)
Cell Treatment Dex Alone Dex + Galaotin
Recombinant 26.16±4.50* 39.82±2.84*
Untransfected 63.19±7.62 61.87 ±1.85
Values are mean ± standard error of the mean. *p < 0.01. n = 18.
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Table 7. Rate of Motility for Recombinant and Control Sparse Cell
Cultures treated with Dex and Galaptin (//m per hr).
Total Motility (//m/hr)
Cell Treatment Dex Alone Dex + Galaotin
Recombinant 6.54±1.13* 9.96±0.71*
Untransfected 15.80±1.91 15.48 ±0.46
Values are mean ± standard error of the mean. *p < 0.01. n = 18.
122
Table 8. Total Motility of Recombinant and Control Confluent Cell
Cultures treated with Dex and galaptin after 4 hr.
Total Motility (//m)
Cell Treatment Dex Alone Dex + Galaotin
Recombinant 34.49 + 1.37* 42.08 ±2.89*
Untransfected 97.03 ±3.00 94.18±3.31 *
Values are mean ± standard error of the mean. *p < 0.01. n = 15.
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Table 9. Rate of Motility for Recombinant and Control Confluent Cell
Cultures treated with Dex and Galaptin (//m per hr).
Total Motility (yum/hr)
Cell Treatment Dex Alone Dex + Galaotin
Recombinant 8.48 ±0.36* 10.52±0.72*
Untransfected 24.26±0.75 23.55 ±0.83
Values are mean ± standard error of the mean. *p < 0.01. n = 15.
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cells and 4.29±0.51 x 10^ vector transfected cells. At 4 hr, the number of
cells that adhered to the laminin coated surfaces increased dramatically to
4.29 ±0.41 X 10^ for the recombinant culture, 6.83 ±1.17 x 10^ for
untransfected control and 7.50±0.29 x lO'^ for vector transfected control
(Figure 23). These changes were statistically significant at p < 0.05. At 6
hr, the 4.52 ±1.26 x 10^ recombinant cells, 8.63 ±0.61 x lO'* untransfected
cells and 7.09 ±0.63 x 10^ vector transfected cells bound to the laminin
coated plates (Figure 23). A similar pattern of adherence was observed for the
recombinant and control cells in the ECL-matrix coated plates. At 2 hr,
1.88±0.25 X 10^ recombinant, 4.18±0.41 x 10^ untransfected and
5.85 ±0.87 X lO'^ vector transfected cells adhered to the ECL-matrix coated
plates. At 4 hr, the number of cells that adhered to the ECL-matrix surfaces
were 3.96 ±0.46 x 10^ for recombinant cells, 7.46 ±1.00 x 10^ for
untransfected cell and 7.50 ±0.87 x 10“^ for vector transfected cells (Figure
24). Again at 6 hr, 4.53 ±0.74 x 10^ recombinant cells adhered to the ECL-
matrix plates compare with 9.22±0.61 x 10^ for untransfected cells and
8.57 ±0.75 X lO'^ (Figure 24). This is also statistically significant at p < 0.05.
Thus, it can be said that recombinant cells adhered to the laminin and ECL-
matrix coated plates at a 50% reduced rate compared with controls (Figures
23 and 24). Again, the selected clones Rec-1 and Rec-3 adhered to the
laminin and ECL-matrix coated plates as the parent recombinant culture after
2, 4, and 6 hr (Figures 23 and 24). However, no significant differences were
125
Figure 23. Total number of recombinant and control cells that adhered to the
laminin coated plates after 6 hr. Cells (1 x 10®) were seeded on laminin coated
plates. They were washed twice with PBS (pH 7.4). Then, trypsinized with
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Figure 24. Total number of recombinant and control cells that adhered to the
ECL-matrix coated plates after 6 hr. Cells (1 x 10®) were seeded on ECL-
matrix coated plates. They were washed twice with PBS (pH 7.4). Then,
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Figure 25. Total number of recombinant and control cells that adhered to the
gelatin coated plates after 6 hr. Cells (1 x 10®) were seeded on gelatin coated
plates. They were washed twice with PBS (pH 7.4). Then, trypsinized with
trypsin-EDTA and counted on the hemocytometer at 2, 4 and 6 hr.
Totalcellsbound(1x10^)
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Figure 26. Total number of recombinant and control cells that adhered to the
uncoated plastic plates after 6 hr. Cells (1 x 10®) were seeded on uncoated
plastic plates. They were washed twice with PBS (pH 7.4). Then, trypsinized
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observed between the recombinant and control cells adhering to gelatin coated
and/or uncoated plastic plates (Figures 25 and 26). Similar results were
obtained on antisense, sense and random oligonucleotides (oligos) treated cells
adhering to the laminin and ECL-matrix protein coated plates (Figures 27-28).
Treatment of SMC with antisense oligos for 24 hr before seeding on the ECM
protein coated plates resulted in an approximate 45% reduction in cell binding
compared to sense and random oligos treated cells (Figures 27 and 28).
Next, the effect of galaptin on the adherence of both the recombinant
and control cells to laminin, ECL-matrix, gelatin coated surfaces and uncoated
plastic surfaces was assessed. As shown in Figures 29-30, the presence of
galaptin caused a reduction in the number of control cells adhering to the
laminin and ECL matrix coated surfaces after 6 hr of incubation. In order
words, the presence of galaptin caused an approximate 55% decrease in the
control cells adhering to the laminin and ECL-matrix coated plates (Figures 29
and 30). These differences are statistically significant at p < 0.05. No
significant differences were observed in the adherence of the control cells to
the gelatin coated and/or uncoated surfaces after 6 hr of incubation (Figures
31-32). This was expected in the uncoated plastic and gelatin coated plates
because of absence of ECM proteins. However, no significant difference was
observed in the binding capacity of the recombinant cells to either the coated
and/or uncoated plastic surfaces in the presence or absence of galaptin,
(Figures 29-32).
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Figure 27. Total number of cells that adhered to the laminin coated plates
after 6 hr. Cells were treated with antisense oligonucleotides for 24 hr.
Control cells were treated with sense and random oligonucleotides. They were
trypsinized with trypsin-EDTA and 1x10® cells were seeded on laminin coated
plates. Cell adhesions were monitored for 2, 4, and 6 hr, respectively. Values
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Figure 28. Total number of cells that adhered to the ECL-matrix coated plates
after 6 hr. Cells were treated with antisense oligonucleotides for 24 hr.
Control cells were treated with sense and random oligonucleotides. They were
trypsinized with trypsin-EDTA and 1x10® cells were seeded on ECL-matrix
coated plates. Cell adhesions were monitored for 2, 4, and 6 hr, respectively.
Values are plotted as means ± standard error of the mean (sem).
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Figure 29. Total number of cells that adhered to the Laminin coated plates in
the presence and/ or absence of galaptin after 6 hr. Plates were coated with
10 //g/ml of Laminin. Coated plates were blocked with 1 % BSA and washed
with PBS (pH 7.4) to remove non-adhered proteins. Cells (1 x 10®) were
seeded in the presence and/or absence of 0.1 //g/ml of galaptin. Adhered cells








Figure 30. Total number of cells that adhered to the ECL-Matrix coated plates
in the presence and/ or absence of galaptin after 6 hr. Plates were coated with
10 //g/ml of ECL-Matrix. Coated plates were blocked with 1 % BSA and
washed with PBS (pH 7.4) to remove non-adhered proteins. Cells (1 x 10®)
were seeded in the presence and/or absence of 0.1 /yg/ml of galaptin. Adhered







Figure 31. Total number of cells that adhered to the gelatin coated plates in
the presence of galaptin after 6 hr. Plates were coated with 10 //g/ml of
gelatin. Coated plates were blocked with 1 % BSA and washed with PBS (pH
7.4) to remove non-adhered proteins. Cells (1 x 10®) were seeded in the
presence and/or absence of 0.1 //g/ml of galaptin. Adhered cells were






Figure 32. Total number of cells that adhered to the uncoated plates in the
presence and/or absence of galaptin after 6 hr. Cells (1 x 10®) were seeded
in the presence and/or absence of 0,1 //g/ml of galaptin. Adhered cells were




Effect of Transfection on the Morphology of Vascular Smooth Muscle Cells:
The question to be answered here is, "Does transfection of vascular
SMC with recombinant gene affect the shape and membrane activities of the
cells?" In order to answer this question, the phase contrast and scanning
electron microscopic methods were employed to study the morphological
changes and membrane activities of the recombinant and control cultures in
the presence and/or absence of Dex. In the absence of Dex, both the control
and recombinant cells were elongated and spindle shape in morphology under
a phase microscope (Figure 33). However, in the presence of Dex, the
recombinant cultures appeared more rounded in morphology with enlarged
cytoplasmic area and large nuclei (Figure 34). The control cells were elongated
and spindle shaped in the presence of Dex. In some cases, recombinant cells
upon staining had multiple nucleoli. The enlarged cytoplasm may be a result
of incomplete replication of DMA and cytokinesis during the cell cycle, thereby
causing the cells to bulge (Figure 34). Using the scanning electron
microscope, it was shown that cultured recombinant cells exhibited reduced
membrane rufflings at 450X, 10OOX and 2500X magnifications as shown in
Figure 34. The reduced membrane ruffling may contribute to the reduced
membrane activities or celhcell interactions and reduced surface motility in the
cultured recombinant cells. This model establishes experimentally that a
reduction in galaptin leads to a decrease in cell proliferation, cell migration, cell
adhesion when recombinant cell culture was treated with 0.1 //M Dex.
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Figure 33. Effect of transfection of vascular SMC with recombinant gene on
cell morphology in the absence of Dex. Phase micrographs of: A,
untransfected cells; B, vector transfected cells and C, recombinant transfected
cells. Pictures were taken at 200X magnification.
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Figure 34. Effect of transfection of vascular SMC with recombinant gene on
cell morphology following induction with Dex. Phase micrographs of: A,
untransfected cells; B, vector transfected cells and C, recombinant transfected
cells. Pictures were taken at 200X magnification.
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Figure 35. Scanning electron micrographs showing the presence of membrane
rufflings in the untransfected, vector transfected and recombinant cells at
different magnifications (A, D and G at 450X; B, E and H at 1,000X; and C,
F and I at 2,500X). A to C represented untransfected cells; D to F represented
vector transfected cells; and G to I represented recombinant cells. Cells were
grown to confluency in T-25 cm^ flasks and fixed with histochoice cell fixative
solution and O2O4. Samples were dehydrated in increasing serially diluted
alcohol solutions and coated with gold/palladium. Pictures were taken at




We have successfully designed, constructed and cloned galaptin cDNA
which was oriented in the antisense direction downstream of the pEBVHis
promoter. Our previous study demonstrated that synthesized 5' end fragment
oligonucleotides proved most effective in reducing galaptin level in vascular
SMC (Bosah and Sanford, 1993). In this study, blocking of galaptin
expression by antisense cDNA yielded the most effective method to investigate
the functions of galaptin in vascular SMC (Bosah and Sanford, 1993). The
experimental results obtained from the constructed recombinant cell culture
model and the correlation of galaptin expression level suggested that galaptin
is an important factor in vascular SMC proliferation, adhesion and migration
during lung development and vascular remodeling. We believe that this model
will be an important tool that could be used to study other roles played by
galaptin in different cell lines. We planned to use this recombinant cell model
to study the mechanism of action of galaptin secretion into the extracellular
matrix. It is known that galaptin is synthesized in the cytoplasmic ribosomes
(Wilson et al., 1989) and secreted extracellullarly, but the exact method of
secretion has eluded research scientists for some time. At present.
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investigators are probing into the mechanism of secretion and the exact
function of galaptin secretion into the extracellular matrix (ECM),
It has been shown (Bosah and Sanford, 1993) that antisense
oligonucleotides added directly to cultured SMC decreased galaptin expression
thereby inhibiting proliferation of vascular SMC. This finding as well as the
fact that galaptin plays important roles in the proliferation and differentiation
of vascular SMC during postnatal lung development, prompted the following
question. Does transfection of vascular SMC with recombinant and clonal
selection have a similar effect on the proliferation of SMC? To address this
question, one must consider the following. Dex has been shown to increase
vascular SMC in vivo and in vitro (Sanford et al., 1992). Souza et al. (1994)
have used antisense oligodeoxynucleotides to inhibit cell proliferation during
embryonic rat lung development. They targeted antisense oligos to PDGF-S
mRNA which resulted in inhibition of translation of PDGF-B protein, and a
significant reduction in lung size compared to control cultures, thus implicating
PDGF-S in lung branching morphogenesis. Data presented here showed
significant decrease in the translation of galaptin mRNA in the recombinant
cells. Further, selection by hygromycin led to characterization of nine clones
containing galaptin antisense cDNA. All clones analyzed showed similar
inhibition of cell proliferation to that of parental recombinant cells. The
doubling time in both the parental recombinant cell culture and selected clones
increased when compared to the controls. Video imaging analysis and
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proliferation assay were used to calculated the cell cycle time. It was found
that the recombinant cells completed mitosis at about 28 to 30 hr compared
to 16 hr for the control cells (Figure 15). The lengthening of cell cycle time of
the recombinant cells can be attributed to the inhibition of galaptin synthesis
leading to reduced rate of proliferation. The down-regulation of galaptin after
transfection with the recombinant gene suggested the involvement of galaptin
in cell proliferation.
Not only were cell numbers higher in Dex induced controls, increases
were seen in the fraction of total cells entering the S-phase as determined by
[^H]-thymidine incorporation into the total DNA after 48 hr. Treatment of cells
with Dex resulted in about 50-60% increase in DNA synthesis in control cells
compared to recombinant cells (Figure 17). There was no significant
difference in the uninduced control and recombinant cells (Figure 15). These
findings demonstrate that galaptin play a major role in proliferation.
These current findings show that the galaptin gene is hormonally and
developmentally regulated in vascular SMC. Upon treatment of the cells with
Dex, translation of the galaptin gene was repressed in the recombinant cells
while Dex induction increased galaptin expression in control cells. The Dex-
induced expression in the control cells was stable and long-lasting. This is
shown in Figures 9-12 where the galaptin expression is about 50-55% higher
in control cells compared to recombinant cells after 48 hr. The Dex-induced
expression in the control cells responded to cellular functions (proliferation.
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migration and adhesion) at much higher rates compared to Dex induced
recombinant and uninduced cells. Treatment of recombinant cells with Dex
resulted in a 50-55% decrease of galaptin expression as shown by
immunoprecipitated [^®S]-methionine metabolically labeled galaptin (Figures 12
and 13). Therefore, expression of immunoreactive galaptin was reduced by
almost 55% in the recombinant cell culture as demonstrated by immunoblot
analysis and [^®S]-methionine metabolic labeling of galaptin (Figure 11). These
studies have demonstrated that transfection of vascular SMC with the
recombinant gene not only resulted in a significant inhibition of proliferation
and a decreased cell number but also a decrease in galaptin expression.
In view of the above results, scanning electron microscopic analysis was
performed to examine the general cell surface morphology (membrane rufflings
and activities) of each cell group following induction with Dex. The Dex
induced recombinant cells exhibited less membrane ruffling that resulted in less
membrane activities, cell to cell interaction and cell migration (Figure 35). The
decrease in membrane rufflings was particularly noticeable in sparsely seeded
recombinant cultured cells.
Noticeable phenotypic differences between the Dex induced recombinant
and control cells were observed. From the phase micrographs, the
recombinant cells appeared more rounded in morphology with enlarged
cytoplasmic areas and/or multiple nuclei when induced with Dex (Figure 34).
The control cells were elongated and spindle shaped in the presence and/or
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absence of Dex (Figure 34). However, no phenotypic differences were
observed between the uninduced control and recombinant cells (Figure 33).
The data presented strongly suggest that the observed phenotypic effects in
recombinant cell culture were mediated by galaptin inhibition. This was
supported by findings that reduced membrane rufflings and activities correlated
with decreased cell migration and adhesion to ECL-matrix and laminin coated
plates by the recombinant cells. If recombinant cells bound to ECM protein
coated plates at a very reduced rate, it may be that the recombinant gene
altered the synthesis of ECM proteins and/or receptors as a result of galaptin
inhibition. More studies are needed to clarify this hypothesis.
One important aspects of this study was determine if inhibition of
galaptin expression resulted from reduced mRNA translation in response to Dex
treatment in the recombinant cells. To address this question. Northern and
Slot blot analyses were performed on mRNAs from the control and
recombinant cells at 48 hr following induction with Dex. This induction did not
lead to any significant difference in the level of mRNA messages in the control
and recombinant cells (Figures 5-8). These results were observed In the
presence and/or absence of Dex. This is consistent with the idea that the
recombinant vector expression does not act at the level of transcription but
rather at the level of translation. This block of the translation of galaptin
mRNA occurs by way of hybridization of the antisense message to galaptin
mRNA, since the translation factors were not able to access the mRNA during
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protein synthesis.
The migratory properties of vascular SMC were examined because
galaptin has been shown to play a role in migration of different cell lines
(Morimoto etal., 1991, Muir, 1993, Koppel and Rabinovitch, 1993). The rate
and total distance migrated by recombinant cells that express little or no
galaptin, and control cells that express galaptin were determined. Cell
migration is a complex process involving the continuous reconstitution of
cytoskeleton by assembling and disassembling actin filaments and the
synchronized detachment from and attachment to the ECM proteins. Previous
studies have shown that these cells express on their surface the membrane
integrins VLA-2 and VLA-5 (Crouch et al, 1994). These integrins bind ECM
proteins such as laminin, collagen type IV, fibronectin and others (Abelda and
Buck, 1990). Two distinct proteolytic fragments of laminin, PI (pepsinic
digestive product) and E8 (elastase digestive product) have been shown to
promote cell adhesion and migration of different cell lines (Aumailley et al,
1987; Goodman et al., 1987 and Lissitzky et al, 1989). The migratory
properties of each cell group were assessed by video image analysis of sparse
and confluent cultures where an area of the culture was denuded.
In the first part of the analysis, sparse recombinant cultures induced
with 0.1 jjM Dex showed a 50-60% reduction in rate of movement over the
4 hr measurement period compared to either untransfected or vector
transfected controls (Tables 2 and 3). Uninduced cells showed no significant
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difference in rate of movement (Tables 2 and 3). The reasons for the decline
in the rate of movement may be attributed to the presence of less cytoskeletal
interactions or signaling by the corresponding integrins of the recombinant cells
(Ocalan et al., 1988 and Levi et al., 1990). Treatment of sparse recombinant
cells with 0.1 >7g/ml of galaptin three hours prior to video image analysis
increased the migratory activities by about 20-30% over a 24 hr period (Tables
6-9). But, galaptin neither increased nor decreased the migratory properties
of the control cells over the 24 hr period.
In the second part of cell migration analyses, both the sheet migration
assay and video imaging analysis were used to monitor the migration of
confluent cell cultures into a denuded area. In the sheet migration assay, the
Dex induced recombinant cells migrated to the denuded area at a slower rate
(approximately 50-60%) compared to the control cells (Figures 18-22). The
recombinant cells showed about a 60% decrease in motility over 24 hr
compared to untransfected or vector transfected control cultures (Tables 4 and
5). No significant differences were observed in the migration of uninduced
recombinant cultures when compared to the uninduced control cultures.
Similar results were observed in the video imaging analysis after 4 hr.
Treatment of Dex-induced recombinant cultures with 0.1 //g/ml galaptin
increased cell migration by about 20 to 30%, suggesting that extracellular
galaptin can partially restore migration to these recombinant cells (Figure 22
and Tables 8-9). These results demonstrate that galaptin is a required factor
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for SMC migration and may be an important factor in vascular remodeling.
Having established a stable vascular SMC line that expresses the
galaptin antisense RNA, but only after clonal selection with hygromycin
antibiotics, one can ask, if the expression of antisense galaptin RNA in these
cells disrupt their binding to the laminin and ECL-matrix coated or uncoated
plastic plates? This question was first addressed by incubating vascular SMC
with different concentrations of synthesized phosphomethyl antisense
oligonucleotides for 24 hr. The treated cells were detached and seeded on an
ECL-matrix and laminin protein coated surfaces. The adherence was monitored
for 6 hr. The antisense oligonucleotides (20 mers) was complementary to the
5'-end of galaptin DNA. The control cultures were incubated with sense
and/or random oligonucleotides. A 45% inhibition of cell adhesion to both
ECL-matrix and laminin coated plates was observed in antisense oligo
incubated cultures compared to the control cultures (Figures 27 and 28). This
inhibition was dose-dependent, that is the inhibition was more pronounced
with increasing concentration of antisense oligonucleotides. Incubating
vascular SMC with antisense oligos for 48 hr before plating on the ECL-matrix
and laminin coated plates did not dramatically reduce the number of cells
adhering beyond the number observed in 24 hr of incubation. Whether
transfection of vascular SMC and clonal selection interfered with adhesion of
recombinant cells to the ECM protein coated plates was also a question that
was addressed in this studies. Recently, many studies have shown that when
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L-14 is released into the extracellular matrix (ECM), it interacted with ECM
proteins including laminin and thereby decreased the adhesion of some cell
lines to ECM proteins (Barondes, 1990 and Skrincosky et al, 1993). In this
current study, ECM proteins composed of laminin and ECL-matrix were used
because of their involvement in different biological activities (both in vivo and
in vitro) including promoting attachment of different cells, migration of tumor
cells and cell-cell interactions. ECL-matrix consists of three extracellular
proteins called entactin (M, « 158 kDa), collagen (M, » 200-350 kDa) and
laminin (M, » 800 kDa). It was known that cell-substratum or cell-cell
interactions are mediated through different receptors including integrin,
laminin, collagen, fibronectin and other ECM protein receptors (Albelda and
Buck, 1990). These receptors send signals through specific ECM proteins and
ligands on adjacent cells. In 1990, Cooper and Barondes used
immunohistochemistry to show the unusual mechanism by which L-14 (family
of lectin with MW » 14 kDa) is released into the ECM. They postulated that
upon synthesis, L-14 will concentrate in vesicles by evagination. These
vesicles fused with the plasma membrane which pinched off to release L-14
into the ECM. But, they failed to assess the roles of galaptin upon being
released into the ECM. Sato et al (1990 and 1992), reported that
carbohydrate binding protein (CBP30) which is expressed by BHK cells
interacted with glycans present on all laminin fragment-coated plates. As a
result, BHK cell attachment to laminin coated plates was not inhibited by either
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carbohydrate binding protein {CBP-30) specific antibodies or low concentration
of CBP-30. In another study, Cooper et al (1991) demonstrated that L-14
inhibited myoblast adhesion to laminin coated substrate by transfected
myoblast cell lines with a recombinant that constitutively expresses L-14. The
recombinant cells used by Cooper et al. constitutively expressed L-14. Excess
L-14 in the ECM and media could interfere with many cellular processes
including adhesion of cells to ECM protein coated plates. Laminin has been
shown to played an important role in promoting myoblast cell growth,
differentiation, adhesion, and migration during the development of the muscle
(Foster et al., 1987, Goodman et al., 1987 and Ocalan et al., 1988). Results
on the cell adhesion studies obtained here are consistent with what has been
reported by Barondes and Cooper (1990, 1991). Mafune et al. (1989) also
obtained similar results on their cell adhesion studies by using recombinant
cells that expressed the 32 kDa laminin binding protein in the human colon
carcinoma cell line. Transfection of the human colon carcinoma cell line with
RNA antisense recombinant resulted in a 35% reduction in adherence to
laminin coated plates as compared to the non-transfected cell line. A
significant (» 50-55%) decrease in cell adherence to the laminin and ECL-
matrix coated plates for the recombinant and selected clones, Rec-1 and Rec-3
after 6 hr compared to controls has been observed in the current study
(Figures 23 and 24). However, no significant differences were observed for
cells adhering to gelatin coated and uncoated plastic plates (Figures 25 and
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26). After 6 hr of incubation, more cells bound to the ECL-matrix and laminin
coated plates than the uncoated or gelatin coated plates. This is because
vascular SMC adhere, migrate and spread better when seeded on ECM coated
surfaces than when seeded on uncoated plastic or gelatin coated surfaces.
However, the number of cells bound to the uncoated plastic surfaces was
identical to that of gelatin coated surfaces. At present, our results
demonstrate that galaptin plays a role in adhesion of cells to ECM components.
Ozeki et al. in 1993 have demonstrated that lectin plays a role in cell adhesion
by interaction with ECM proteins such as laminin, integrin and fibronectin
through protein-carbohydrate moiety interactions. Therefore, the preferential
adhesion of control cells to laminin and ECL-matrix coated plates compared to
the recombinant can be attributed partly to the presence of galaptin, since, it
binds preferentially to ECM proteins such as laminin and entactin. The
decreased cell number of the recombinant cells seen adhering to laminin and
ECL-matrix coated plates may be due to a decreased efficiency resulting from
decreased expression of galaptin. The decreased adhesion of the recombinant
cells to ECM protein coated plates has been attributed here to the fact that
reduced expression of galaptin may down-regulate the expression of other
adhesion proteins like laminin and elastin receptor {67 kDa protein) as shown
by Mecham, 1991. It could be that the antisense cDNA is also hybridizing to
the laminin and elastin receptor gene since, according to Beck et al. (1990)
and Mecham. (1991) it has a high degree of homology to galaptin. If this were
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true, then, one would expect that laminin (one of the adhesion proteins) would
be greatly reduced as is galaptin in recombinant cells. The number of
recombinant cells observed adhering to the ECM protein coated plates can be
attributed to the availability of the basal integrins and other membrane
proteins. One should not expect 100% inhibition of recombinant cells adhering
to the these coated plates because of the presence of integrins and related
proteins. More studies are need to clarify if decrease expression of galaptin
down-regulates the expression of laminin and elastin receptor.
Also investigated here were the effects of exogenous galaptin on
recombinant and control cell adhesion to ECL-matrix, laminin, gelatin coated
and uncoated plates. Direct addition of 0.1 fjQlxwS of galaptin to the coated
plates before seeding the cells significantly decreased the adhesion of
untransfected and vector transfected cells after 6 hr of incubation. The
decrease in adhesion of the control cells were observed only in ECL-matrix and
laminin coated plates (Figures 29-30) but not in gelatin coated and uncoated
plastic plates (Figures 31-32). As shown in Figure 29, addition of galaptin to
laminin coated plates significantly decreased the adhesion of untransfected
cells by 67% and vector transfected cells by 64%. Also, the presence of
galaptin in the ECL-matrix coated plates significantly inhibited the adhesion of
untransfected cells by 78% and vector transfected cells by 72% (Figure 30).
The decreased binding observed in the untransfected and vector transfected
cells in the presence of galaptin were significant at p < 0.01. The above
165
results were in agreement with other published studies including Cooper et al.
(1990) and Cooper and Barondes (1990). Surprisingly, exogenous galaptin
had no effect on the adhesion of recombinant cells to ECL-matrix, laminin,
gelatin and uncoated plates (Figures 29-32). In other words, presence of
galaptin did not significantly increase or decrease the adhesion of recombinant
cells to the coated or uncoated plates. We postulated that exogenous galaptin
may promote more adhesion of recombinant cells to either the ECL-matrix or
laminin coated plates but not to the gelatin coated and uncoated plates. The
explanations for these effects may be that upon internalization of exogenous
galaptin by the recombinant cells, galaptin does not to restore complete
adhesion as the cytoplasmic synthesized galaptin by the control cells. An
alternate explanation may be that the concentration (0.1 //g/ml) of exogenous
galaptin was too low to restore complete adhesion of recombinant cells to
either ECL-matrix or laminin coated plates.
Our recombinant cell model establishes experimentally that a reduction
in galaptin leads to a decrease in cell proliferation by 50-60%, a decrease in
adhesion by 55% and a decrease in migration by 50-60% when the
recombinant culture was induced with 0.1 jjM Dex. In evaluating the
attachment of the human colon carcinoma cells to laminin coated plates,
Skrincosky et al. (1993) observed a significant decrease in attachment in the
antisense transfected cells while sense transfected cells increased their
attachment. These results strongly demonstrated not only cell adhesion
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properties of recombinant and control cells to the ECM proteins but also the
properties of cell migration and proliferation. However, the variability observed
by different investigators of the action of galaptin on cell adhesion may be due,
at least in part, to the use of different experimental models, culturing




This is the first report of designing, constructing and transfecting
vascular SMC with recombinant vector containing galaptin cDNA which was
oriented in the antisense direction. The methods and results presented in
these studies represent initial steps for other studies that will establish at both
the cellular and molecular levels the roles of galaptin in different cell lines. We
have investigated the role(s) of galaptin in vascular SMC proliferation,
migration and adhesion to selected ECM proteins, and have been able to
demonstrate that the expression of galaptin is significant to these cellular
functions. Based on our previous observations that: (1) the expression of
galaptin increases during the first 14 days of postnatal rat lung development;
(2) the expression of galaptin is hormonally regulated and (3) that galaptin
promotes cell-cell and/or cell-ECM interactions, we hypothesized that
constructing a recombinant model containing galaptin cDNA (oriented for
antisense expression) and pEBVHis vector would be an excellent method to
specifically study cell proliferation, migration and adhesion. Upon inducing
recombinant vascular SMC cultures with 0.1 jjM of Dex, reductions in galaptin
expression by 50-60%, cell proliferation by 55%, cell migration by 50-60%
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and cell adhesion to selected ECM proteins by 55-60% were observed.
In view of the above results, it can be to stated that galaptin was acting
as an intracellular autocrine factor, a point which can be explained by the
proliferative properties of the control cells over recombinant cells. The control
cells expressed 50-55% more galaptin than the recombinant cells when
induced with Dex. At present, no one has addressed the intracellular autocrine
function of galaptin. With the construction and establishment of this model,
the autocrine and other postulated functions of galaptin can now be addressed
using this vascular SMC model.
First, the cytoskeletal arrangements (components) of the recombinant
and control cells can be analyzed by staining for the presence and/or absence
of these elements. This will add more knowledge on the mechanism on which
expression of the cytoskeletal element(s) enable the control cells to adhere to
ECM coated plates and migrate at a faster rate when compared to the
recombinant cells. Secondly, the recombinant cell model will be use to
evaluate the roles galaptin plays in the cell cycle of vascular SMC. Preliminary
studies have demonstrated that the doubling period for recombinant cells were
longer than for control cells. If this happens to be true, then the question
arises to what roles cytoskeletal elements such as microtubules and/or
microfilaments or other proteins such as cyclins might play in causing the
lengthening of the cell cycle in the recombinant cells. How is the absence or
decreased expression of one or more cytoskeletal elements and/or other
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proteins such as cyclins related to the presence and/or function of galaptin?
Also, at what time in the cell cycle is galaptin affecting this lengthening of the
cell cycle? Thirdly, the mechanism of galaptin secretion to the ECM can be
addressed using this model. Barondes et al (1990) have proposed that galaptin
after synthesis on the free cytoplasmic ribosomes is evaginated into small
vesicles and released into the ECM. More studies are needed to elucidate the
exact mechanism of galaptin secretion into the ECM. If galaptin is secreted
into the ECM, what is its specific function there? Published studies on cell
adhesion using ECM proteins have implicated galaptin in cell adhesion activities
inside the ECM (Bosah and Sanford, 1995). Fourthly, we have to assess if the
decreased expression of galaptin specifically down-regulates the expression of
ECM proteins like laminin and elastin receptor (67 kDa protein), especially since
the galaptin gene has a high degree of homology to this 67 kDa gene. It could
be that the galaptin antisense cDNA is hybridizing to the homologous sequence
of the 67 kDa gene. It is important to asses the presence and/or quantity of
laminin and elastin receptor at the time of galaptin inhibition in the recombinant
cells. In situ hybridization using specific laminin/elastin receptor probe can be
used to quantify and localize the expressed 67 kDa protein and Northern
blotting with specific probe can be used to assess the presence and/or quantity
of this protein at the time of galaptin inhibition.
Over the past seven years, many studies have demonstrated that
antisense DNA is capable of inhibiting the expression of a specific gene in both
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bacterial or mammalian cells, thereby allowing investigators to assess the
functionfs) of a particular gene (Izant and Weintraub, 1984). The antisense
DNA and/or RNA can be introduced into the cells by direct (adding to the
media) or indirect (vector or liposome mediated) methods. The introduction
can be either stable or transient in the cells. Our results demonstrate that
recombinant vascular SMC containing pEBVHis vector and antisense cDNA
repressed galaptin expression leading to inhibition in cell proliferation,
migration, and adhesion by vascular SMC.
Finally, the most important outcome of these studies is that a way of
reducing galaptin expression in vascular SMC without altering the synthesis of
total protein have been developed, thereby allowing us to assess the molecular
and cellular functions of galaptin in vascular SMC or in other cell lines. This
model can be used to study the role(s) of galaptin or other protein(s) in the
same or different cell line(s).
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